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ABSTRACT 
 
The transmission of genetic information from the transcription of DNA to RNA and the subsequent 
translation of RNA into protein is often abstracted into a linear process. However, as methods and 
technologies to measure the genomic, transcriptomic, and proteomic content of cells have 
advanced, so too has our understanding that the transmission of genetic information does not 
always flow in a lossless manner. For instance, changes observed in messenger RNA (mRNA) 
abundance are not always retained at the proteomic level. Indeed, a diverse array of mechanisms 
have been identified that exert regulatory control over this transmission of information. Next-
generation short read sequencing has driven many of these insights and provided increasingly 
nuanced understanding of these regulatory mechanisms. However, the continued development and 
application of sequencing methodologies and analytics are required to properly contextualize many 
of these insights on a more global scale. Ribosome profiling is one such recent advancement which 
enriches for ribosome-protected fragments of mRNA; sequencing and analysis of these ribosome-
protected mRNA fragments enables profiling of the translational content of a sample. The aim of 
this dissertation is to address the need for the development and application of statistical and 
analytical algorithms to profile the regulatory factors that contribute to the translational dynamics 
in cells. 
 
In the first chapter, I survey the development and application of next-generation sequencing 
methods for the profiling and computational analysis of translation and translational dynamics. In 
 xiv 
 
the second chapter of this thesis, I present SPECtre, a software package that identifies regions of 
active translation through measurement of the translational engagement of ribosomes over a 
transcript. SPECtre achieves high sensitivity and specificity in its classification of regions 
undergoing translation by leveraging the codon-dependent elongation of peptides; this tri-
nucleotide periodicity is evident in the alignment of ribosome profiling sequence reads to a 
reference transcriptome. SPECtre classifies actively translated transcripts according to their 
coherence in read coverage over a region to an optimal tri-nucleotide signal. 
 
In the third chapter, I describe the application of SPECtre to identify the translation of upstream-
initiated open-reading frames that may regulate differentiation in a neuron-like cell model. uORFs 
are transcripts that result from the initiation of translation from AUG, and under certain biological 
constraints, from non-AUG sequences localized in the 5’ untranslated regions of annotated protein-
coding genes. Subsets of these uORFs have been implicated in the regulation of their downstream 
protein-coding genes in yeast, mice and humans. In this chapter, I provide further evidence for this 
regulation as well as the spatial context for the functional consequences of uORF translation on 
downstream protein-coding genes in a neuron-like cell line model of differentiation. 
 
Finally, in the fourth chapter, I outline a strategy using our coherence-based translational scoring 
algorithm to profile ribosomal engagement over chimeric gene fusion breakpoints in prostate 
cancer. Here, known breakpoints from current annotation databases are integrated with novel 
junctions nominated by existing whole genome and transcriptomic gene fusion detection 
algorithms, and the translational profile over these chimeric junctions using SPECtre is measured. 
This provides an additional layer of translational evidence to known and novel gene fusion 
 xv 
 
breakpoints in prostate cancer. Ongoing development of a database and visualization platform 
based on these results will enable integrative insights into the transcriptional and translational 
topology of these breakpoints.
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CHAPTER 1 
INTRODUCTION 
 
1.1 Translation 
 
The transmission of genetic information may be conceptualized as a linear process where double-
stranded DNA is transcribed into a single-stranded mRNA, and the translation of this mRNA into 
functional protein (Figure 1.1).[1] However, this transmission of encoded information in the 
genome from DNA into RNA to protein is subject to multiple points of coordinated governance; 
these include, but are not limited to, changes in DNA conformation, epigenetic regulation, 
transcription and post-transcriptional control, and translational and post-translational regulation. 
These regulatory mechanisms and checkpoints can exert profound, often non-linear effects on the 
ultimate abundance of protein in a cell.[2-10] 
 
Translation is the mechanism by which the information encoded by an mRNA is converted into a 
protein through the systematic addition of tri-nucleotide sequences, alternatively referenced as 
codons or amino acids, by ribosomes. Thus, ribosomes and their associated complexes represent 
the translational machinery of a cell. Translation can be roughly divided into four parts: initiation, 
elongation, termination, and ribosomal dissociation. In eukaryotes, translation initiation is 
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typically mediated by a pre-initiation complex comprised of eIF2 bound to methionyl-initiator 
tRNA and a 40S ribosomal subunit. eIF4 facilitates the binding of the PIC to the 5’ end of a 7-
methylguanosine (m7G) capped nascent mRNA and scans to the 3’ end until an AUG tri-nucleotide 
translation initiation sequence is recognized.[11,12] In certain instances, translation may initiate 
from non-AUG near-cognate codons, and under other biological contexts translation may 
alternatively initiate from non-AUG non-cognate sites.[11,13] Upon successful initiation, a 60S 
ribosomal subunit is engaged by the PIC to form a complete 80S ribosomal complex, which 
mediates the elongation of the emergent peptide through the systematic recruitment and addition 
of subsequent tri-nucleotide codons. Peptide elongation proceeds until one of three in-frame 
termination signal moieties are recognized, at which point the 80S ribosomal complex is 
dissociated and the peptide completes its structural formation into protein. 
 
1.2 Regulation of translation initiation 
 
Although regulatory mechanisms may positively or negatively affect translation during elongation, 
termination or ribosomal dissociation, translational regulation at the point of initiation has been 
more comprehensively studied.[14-16] Briefly, regulation of translation initiation has multiple 
points of control including sequence context, mRNA secondary structure, or translation of 
alternative upstream open-reading frames.[17] 
 
As mentioned previously, translation is typically initiated at AUG tri-nucleotide start sites. 
However, favorable flanking sequence context may enrich for initiation at specific AUG sites over 
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others. In bacteria, the Shine-Dalgarno (SD) sequence is a sequence motif that enhances the 
recruitment of the PIC to AUG initiation sites and promotes protein synthesis.[18] In eukaryotes, 
context for the site-specific preference of certain AUG sites over others is provided by the flanking 
Kozak consensus sequence.[12] Due to the 5’ to 3’ directionality of the scanning PIC, the AUG 
closest to the 5’ end of the m7G-capped mRNA typically dictates translation initiation. However, 
presumptive AUG initiation sites may be skipped by the PIC, termed leaky scanning, if their 
flanking sequence context is unfavorable (e.g. lacking a Kozak consensus sequence). 
Alternatively, near-cognate non-AUG tri-nucleotides, that differ from the canonical AUG 
initiation sequence by a one base substitution, may be selected by the PIC to initiate translation. 
Translation initiation from near-cognate sites is typically mediated by the abundance and activity 
of additional eIFs, such as eIF1 and eIF5.[19,20] eIF1 and eIF5 have cross-regulatory effects on 
the initiation of translation from near-cognate sites; eIF1 promotes the utilization of non-AUG start 
codons, whereas eIF5 antagonizes eIF1-mediated non-AUG near-cognate site translation 
initiation. 
 
Shorter 5’UTRs, generally less than 20 nucleotides in length, may be prone to leaky scanning and 
have a detrimental effect on the translational efficiency of the encoded mRNA.[21,22] Further, the 
secondary structure of the 5’ capped mRNA transcript may also modulate the efficiency of 
translation initiation. Longer 5’UTRs with a stable stem-loop structural conformation may stall the 
scanning PIC and promote the usage of sub-optimal AUG sites, or in some cases, bias translation 
initiation from near-cognate non-AUG start codons.[23] In addition, the normal scanning 
mechanism of the 5’ capped mRNA by the PIC may be circumvented by internal ribosome entry 
sites; IRES are sequence elements that promote the entry of the PIC into the 5’UTR in a m7G-
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independent manner.[24] Taken together, specific sequence motifs in the 5’UTR or secondary 
structural conformation may promote the binding and recruitment of proteins and complexes that 
regulate the initiation of translation, sometimes from sites upstream of the canonically encoded 
protein-coding sequence translation initiation start site. Translation initiation and elongation of 
open-reading frames from these upstream start sites can modulate the translational efficiency of 
the canonical protein.[25-30] These ORFs may terminate upstream of the annotated protein-coding 
translation initiation site, or at an in-frame or out-of-frame termination site that overlaps the 
canonical CDS. The translation of upstream-initiated ORFs, inclusive of those terminated 
proximally upstream and within the canonical CDS, may hinder the translation of the annotated 
protein in a resource-dependent or sterically competitive manner.[31]  
 
For instance, translation of one of two experimentally validated ORFs initiated upstream of the 
transcriptional regulator ATF4 are dependent on the phosphorylation of eIF2 in response to cellular 
stress.[32] ATF4 mediates the expression of genes that mitigate damage caused by cellular 
stress.[33,34] The translation of ATF4 is governed by two ORFs: uORF1, which terminates 
upstream of the ATF4 CDS, and uORF2, which terminates within the annotated CDS of ATF4. 
The 5’ proximal uORF1 is a positive-acting cis-regulatory element that modulates ribosomal 
scanning and re-initiation of the downstream ATF4 coding sequence.[35] When eIF2-GTP is 
abundant under normal, non-stressed conditions, scanning ribosomes downstream of uORF1 re-
initiate at uORF2, which inhibits translation of the ATF4 protein. In stressed conditions, eIF2 is 
phosphorylated and results in a reduction of free eIF2-GTP; reduced levels of eIF2-GTP increases 
the time required for the scanning ribosomes to re-initiate translation at uORF2. Thus, ribosomes 
downstream of uORF1 scan through and do not re-initiate translation of uORF2, instead translation 
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is re-initiated at the ATF4 CDS, which in turn promotes the transcription of downstream target 
genes in response to cellular stress.[35-37] 
 
1.3 Upstream open-reading frames and disease 
 
Translation of upstream-initiated ORFs contributes to the regulatory circuitry of a cell; indeed, 
their dysregulation has been implicated in the development and progression of various diseases. 
Sequence variants that introduce, ablate, or otherwise disrupt upstream-initiated ORFs may alter 
the translational efficiency of the downstream protein-coding sequence and affect phenotypic 
outcomes.[31] A 4 nucleotide deletion in the 5’UTR of the cyclin-dependent kinase inhibitor 
CDKN1B results in a frame-shifted termination signal of an upstream-initiated ORF leading to a 
reduction in the intercistronic space between the normally encoded uORF and the downstream 
CDS.[36] As a consequence, the efficiency of translation re-initiation at the CDKN1B CDS is 
decreased and results in down-regulation of the cell cycle inhibitor p27; patients with under-
expression of p27 often develop multiple endocrine neoplastic syndrome.[37] Furthermore, 
translation may alternatively initiate from upstream non-AUG sequences; translation initiation 
from near-cognate and non-cognate AUG start sites have also been implicated in the etiology of 
different diseases. Expansion of a CGG tri-nucleotide repeat in the 5’UTR of the fragile X gene 
FMR1 induces a conformational change in the secondary structure of the nascent mRNA which 
promotes the recruitment of the 40S PIC to initiate translation in the absence of an AUG or near-
AUG start site sequence.[38] Therefore, the translation of upstream-initiated ORFs comprise an 
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additional layer of complexity in the regulatory topology of both normal cellular function and 
disease-associated phenotypes. 
 
1.4 Other regulatory factors that affect protein abundance 
 
The abundance of mRNA in a cell may by modulated by transcriptional and post-transcriptional 
regulatory mechanisms, and the ultimate readout as proteomic abundance may be obscured 
biologically by other post-translational means. Exhaustive and ongoing research efforts have 
characterized many of these mechanisms, therefore only selected regulatory pathways that 
moderate mRNA and protein abundance are detailed here. 
 
Similar to translation initiation, sequence-specific moieties and changes in structural conformation 
can promote, or alternatively, repress the transcription of DNA into RNA. In general, DNA is 
structurally condensed and organized around histones; and various proteins and transcription 
factors may act to mediate the accessibility of that DNA to the transcriptional machinery of the 
cell.[39] Sequence motifs in the 5’UTR, and in particular the 3’UTR may specifically bind small 
non-coding microRNAs; microRNAs bound to the 3’UTR of protein-coding transcripts may 
selectively target them for degradation.[3,40,41] In this way, post-transcriptional regulation of 
protein-coding genes by microRNAs may alter their ultimate abundance in the proteome.[42] 
Alternatively, termination signals in-frame to the canonical translation termination site in the CDS 
of protein-coding genes may trigger the nonsense-mediated decay pathway and repress the 
abundance of certain proteins.[43] Finally, post-translational modifications may alter the stability, 
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activity and, in some cases, the localization of proteins; altogether, these mechanisms contribute 
to determine the proteomic fate of various mRNA transcripts, or may constrain the accessibility of 
some proteins to orthogonal detection methods.[44] 
 
1.5 High-throughput sequencing and RNA-Seq 
 
The sequencing and assembly of the human genome ushered in an era of unprecedented discovery, 
and was made possible only by the inestimable efforts of thousands of researchers, as well as 
critical methodological and technological innovations.[45,46] Sanger sequencing, whole genome 
shotgun sequencing, and computational assembly algorithms empowered the completion of the 
initial draft of the human genome.[47-49] One unexpected result of the sequencing and assembly 
of the human genome was the paucity of protein-coding genes, especially for an organism 
considerably higher in complexity relative to mice, flies, or even single-celled organisms like 
yeast. Where it was once assumed that the human genome would consist of hundreds of thousands 
of protein-coding genes, scientists and lay people alike were astounded when finalized estimates 
placed this number around roughly 20,000 genes.[50] Thus, efforts were concentrated to develop 
experimental and computational methods to interrogate alternative models of gene expression 
regulation that might provide further insight into the complexity of the human transcriptome and 
proteome. 
 
Highly reproducible, increasingly sensitive and massively parallel methods were developed to 
isolate and amplify selected sequences, and then computationally assess their composition at single 
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nucleotide resolution through the marriage of biochemical readouts and imaging technologies. In 
this way, total RNA-Seq and mRNA-Seq, and high-throughput protein arrays and mass 
spectrometric methods were developed to interrogate the transcriptomic and proteomic content of 
a cell, respectively.[51-56] In a typical mRNA-Seq experiment, total RNA is extracted from a 
single cell, collection of cells, or organism, and then reverse transcribed into cDNA. Following 
reverse transcription, the cDNA is fragmented into smaller sequences, size-selected, and then 
ligated to sequencing adapters. The adapter-ligated cDNA sequences are then subjected to several, 
or up to dozens of cycles of PCR amplification and then sequenced on a high-throughput 
sequencing machine. Depending on the sequencing technology, an mRNA-Seq experiment can 
produce anywhere from several million to hundreds of millions of single-ended or paired-end 
reads. Paired-end reads leverage the size selection step of library preparation to ligate both ends of 
a cDNA fragment with sequencing adapters; using the expected size distribution between the ends 
of these paired reads, additional information may be extracted upon sequence alignment that can 
aid in the identification of splice junctions or structural variants.[57] Single-end and paired-end 
sequences aligned to a reference transcriptome have been used to infer the relative abundance and 
structure of various RNA species, including non-coding transcripts, protein-coding genes, and 
alternatively spliced isoforms.[58] 
 
1.6 Sequence alignment 
 
After reads are collected from a high-throughput sequencing machine, bioinformatics analysis 
begins with an assessment of sequence content and quality. Artifacts of PCR amplification may be 
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identified and accounted for, if required, in downstream analyses. Prior to alignment, adapter and 
contaminant removal, followed by quality trimming of the sequence reads may be required; since 
many alignment algorithms are sensitive to the quality of reads at single nucleotide resolutions, 
inclusion of low quality nucleotides may affect not only where a read is aligned, but affect the 
overall confidence of its alignment.[59] Due to the biochemical properties of prolonged 
polymerase activity during sequencing-by-synthesis methods, the 3’ ends of reads are often of 
lower quality than those towards the 5’ end of the read.[60] Thus, quality trimming software may 
be used to survey the length of a sequenced read, and then selectively trim its ends if succeeding 
sequences of nucleotides fall below a pre-determined threshold for minimum quality. 
 
Once read libraries have been assessed for sequence content and subjected to quality control 
measures, they are then ready for alignment to a reference genome or transcriptome. Since one-to-
one string comparison of potentially hundreds of millions reads against millions or billions of 
possible reference target locations would be computationally expensive, reference sequences are 
often condensed and indexed using speedy compression algorithms, such as a Burrows-Wheeler 
transformation.[61] Compression and indexing of reference sequence target locations increases the 
speed and efficiency of string alignment search by many orders of magnitude. Representative 
alignment pipelines based on Burrows-Wheeler transformation include BWA, Bowtie, its 
successor Bowtie 2, and the splice-aware aligner TopHat.[62-65] Alternatively, the STAR 
algorithm leverages uncompressed suffix arrays to enable increasingly efficient alignment of 
sequence reads to a reference.[66] Other alignment algorithms, like Sailfish, utilize a k-mer 
assembly approach to estimate the relative abundance of transcripts.[67] Reads aligned to a 
reference genome or transcriptome are assessed for quality based on a number of factors, including 
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but not limited to, individual base pair quality, tolerance for insertions or deletions in the 
alignment, and parsimony of alignment, where sequence reads mapped to multiple loci are often 
scored lower than those that are aligned to unique locations on the reference. Since all subsequent 
analyses, including transcript abundance estimation and structure are based on the overall quality 
of sequence alignment, careful consideration must be given to aligner selection and 
parameterization. 
 
1.7 Estimation of relative transcript abundance from RNA sequencing data 
 
The relative abundance of transcripts and isoform structure may be inferred through assessment of 
those sequence reads that align across, or span, exon-exon splice junctions constructed from a 
reference transcriptome or transcript annotation database. In addition, paired-end sequence 
alignment and careful observation of deviations from the expected distribution of the distance 
between these read pairs can be used to guide increasingly sensitive and specific transcript 
structure assembly, or even identify de novo splice junctions.[58,64] Since the sampling of cDNA 
fragments from which the sequence reads are derived is typically assumed to be random, the 
relative abundance of reads aligned to a transcript may be used to infer its relative abundance. 
Since longer transcripts are more likely to be sequenced, relative transcript abundance is typically 
summarized as a library and transcript length-normalized estimate. RPKM, FPKM or TPM may 
be estimated directly from the number of reads annotated to each transcript, however more 
sophisticated algorithms like Cufflinks and RSEM build statistical models based on alignment 
parsimony to more accurately assemble transcripts and report their relative abundance.[58,68] 
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With multiple replicates, the differential expression of genes or transcript isoform abundance may 
be assessed using statistical metrics, or by using software packages like EdgeR or DESeq.[69-71] 
In this way, it is possible to observe and report global patterns in gene expression or relative 
isoform abundance across conditions or sample cohorts. 
 
1.8 Mass spectrometry and estimation of protein abundance 
 
Protein identification and their relative abundance may be estimated using immunoassay-based 
methods including Western blotting, ELISA, or through reporter-linked immunoluminescent 
readouts like GFP or firefly luciferase.[72-75] Immunoassay-based methods for protein 
identification and abundance estimation may be limited by the availability of high-quality, specific 
antibodies, and the concurrent measurement of multiple protein species in a single experiment can 
be technically challenger, or time and labor intensive. More recently, protein microarrays were 
developed for the high-throughput assessment of protein abundance in a sample; they are relatively 
cheap to produce, and may be customized to experimental requirements. Like immunoassay-based 
methods, protein microarrays may be limited by the availability of suitable bait antigens, and 
protein-protein interactions may not be accurately assessed due to immobilization of secondary or 
tertiary structure. In addition, the overall search space of a protein microarray experiment may be 
artificially constrained by the density available on the chip.[76] 
 
Technological advances in automation and detection sensitivity have enabled increasingly high-
throughput investigation of the proteomic content of a sample using mass spectrometry-based 
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approaches. In a typical high-throughput MS experiment, proteins are selected according to size, 
or by affinity purification. Isolated proteins are then fragmented, their constituent peptides are 
ionized, and the mass-to-charge time of flight of these peptide-ion species is measured. Peptide 
sequences may then be assembled de novo, or more generally, compared against a reference protein 
and peptide sequence database using search algorithms like MASCOT, X!Tandem, 
PeptideProphet, or MSFragger.[77-81] Most search algorithms take an input MS/MS spectrum and 
compare it against a theoretical peptide sequence fragmentation database. Sensitivity and 
specificity of the peptide search against the fragmentation database may be customized, including 
parameterization for mass tolerances allowed, proteolytic enzyme constraints, and for the types of 
post-translational modification that may be considered. The output from the database search is a 
list of peptide sequence matches ranked according to their likelihood of being a positive match. 
Relative protein abundance may be estimated from the number of spectra assigned, or more 
accurately, normalized according to identification parsimony.[82] 
 
1.9 Confounding variables in the comparison of transcriptome and protein abundance 
 
Comparison of transcript abundance estimates based on mRNA-Seq, and those based on MS 
experiments and database search, are positively but only moderately correlated.[83] There are 
several factors which may complicate the comparison of abundance estimates across -omic space, 
some of which have been detailed above. Briefly, post-transcriptional regulation by microRNAs 
may target certain mRNAs for degradative clearance, and may result in anti-correlated transcript 
abundance with protein expression. The translation of some mRNAs into protein may be 
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negatively regulated through competitive or steric inhibition by uORFs. Moreover, PTMs like 
ubiquitination may result in the selective degradation of protein species and subsequent down-
regulation of their abundance when measure by mass spectrometry. In addition, other PTMs may 
alter the structure, activity, or sub-cellular localization of a protein and complicate their isolation, 
fragmentation, or detection using MS-based assays. 
 
Global comparison of transcript expression with protein abundance may be further confounded by 
bioinformatics-based biases inherent to transcriptome or protein searches. For example, liberal 
parameterization of sequence alignment or during transcript assembly may artificially enrich for 
false positive transcript structures, or splice junctions with poor evidentiary support. Peptide 
databases derived from less stringently assembled transcripts may significantly enlarge the 
potential search space, and result in spurious peptide matches. Furthermore, depending on how the 
peptide database is constructed, or its search parameterized, certain transcript variants may be 
alternatively identified as a novel peptide, instead of a post-translational modification of an 
existing peptide. Thus, considerable thought must be given to how comparative studies of 
transcript expression and protein abundance are conducted, and interpreted.[84] 
 
1.10 Translational profiling through sequencing of ribosome-protected mRNA 
 
Ribosome profiling, or Ribo-Seq, is a next-generation high-throughput sequencing methodology 
that was developed to directly investigate the content and dynamics of actively translating 
ribosomes.[85] Ribosome profiling involves the isolation and massively parallel sequencing of 
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ribosome-protected fragments of mRNA; since these mRNA fragments, or footprints, are protected 
from enzymatic digestion during library preparation by their complexed ribosomes, they are 
representative of regions in a transcript under active translation. A typical ribosome profiling 
experiment starts with cellular lysis to isolate mRNA bound by ribosomal complexes. Treatment 
with biochemical translation elongation inhibitors, like cycloheximide, or through combinatorial 
cold-shocking of the samples, immobilizes ribosomal complexes over an mRNA.[86,87] Exposed 
regions of mRNA not protected by a ribosome are enzymatically digested using a ribonuclease, 
and the mRNA:ribosome complexes are isolated using sucrose gradient density centrifugation. 
Ribosomes are proteolytically disaggregated to free the bound mRNA, and the de-coupled mRNA 
is then size selected in order to enrich for a range of 28-30 nt fragments typically protected by a 
ribosome. Sequencing adapters are ligated to the 3’ ends of the isolated fragments of mRNA, 
biotinylated, and then purified to deplete the sample of ribosomal RNA contaminants. The adapter-
ligated mRNA fragments are reversed transcribed into cDNA, subjected to several cycles of PCR 
amplification, and then sequenced on a high-throughput next-generation sequencing machine.[88] 
 
1.11 Bioinformatic considerations for the analysis of ribosome profiling data 
 
Once ribosome profiling library sequence reads are collected from a next-generation sequencing 
machine, the RPFs are removed of sequencing adapters and then trimmed by minimum base 
quality thresholds. Ribosome profiling reads may then be aligned to a reference genome or 
transcriptome using established methods suitable for RNA- or mRNA-Seq experiments. However, 
even after immunoaffinity depletion during library preparation, rRNA contamination can persist 
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in the sequenced ribosome profiling reads due to the presence of several kilobases of rRNA in a 
ribosomal complex.[89] rRNA contaminants can comprise anywhere from 10% to up to 80% of 
sequenced reads in a given ribosome profiling experiment.[90] Thus, prior to alignment, ribosome 
profiling reads are typically aligned to a contaminant sequence database to further deplete them of 
rRNA sequences. Following this bioinformatic depletion of rRNA contaminant species, the 
remaining unmapped reads are then aligned to a reference genome or transcriptome. Alignment 
parameters must be carefully selected, and post-alignment quality control must be judiciously 
applied; because of their shorter length (28-30 nt) compared to the typical length of fragments 
isolated in many contemporary mRNA-Seq experiments (50-150 nt), ribosome profiling reads are 
more sensitive to non-parsimonious alignment.[91] In addition, treatment with different 
biochemical translation elongation inhibitors may enrich for varying lengths of mRNA due to 
changes in the conformation of immobilized ribosomes. Cycloheximide treatment enriches for 
mRNA fragments with an average length of 28-30 nt, whereas immobilization through cold-shock 
alone, enriches for a secondary population of mRNA fragments which range in size from 18 to 22 
nucleotides.[92] 
 
Following alignment, positional analysis of RPFs over a transcript must account for the physical 
localization of an isolated mRNA fragment inside the ribosome.[93] Internal mRNA fragment 
localization is also inhibitor-dependent; cycloheximide is a translation elongation inhibitor that 
induces a conformational change in the E-site of the ribosome.[94] Therefore, the aligned position 
of ribosome profiling sequence reads derived from cycloheximide immobilization must be 
centered to the A-site of the ribosome. In contrast, harringtonine is a translation elongation 
inhibitor that prevents the peptidyl transfer of the amino-acid:tRNA to the nascent peptide. Thus, 
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the aligned position of ribosome profiling reads in harringtonine-derived sequence libraries must 
be adjusted to the P-site of the ribosome. To determine the A- or P-site offset to adjust the aligned 
position of ribosome profiling reads derived from cycloheximide or harringtonine immobilization, 
respectively, reads of the same length that overlap annotated canonical translation initiation sites 
are extracted. Reads of the same length are collected, and the most common distance from the 5’ 
ends of these reads is used to adjust the aligned position of all reads of identical length (Figure 
1.7).[93] For example, if the most common distance from the 5’ end of 28 nt length reads 
overlapping canonical AUG initiation sites is 13 nt, then the 5’ aligned position of all reads 28 
nucleotides in length are adjusted by 13 nucleotides from their 5’ end. In this way, the A- or P-site 
adjusted aligned position of reads is reflective of the structural-dependent position of the ribosome 
over the bound mRNA. 
 
1.12 Identification of regions under active translation 
 
Given some of the limitations of comparative analysis between transcript expression and protein 
abundance, ribosome profiling is strategically positioned to provide an intermediate view of 
translation and translational dynamics. However, because of the generally shorter lengths of RPFs, 
alignment of ribosome profiling sequence reads can be especially sensitive to non-parsimonious 
alignment to multiple locations on a reference genome or transcriptome. Therefore, rudimentary 
coverage metrics may not be sufficiently robust enough on their own to reliably identify regions 
in the transcriptome under active translation. To that end, several algorithms have been developed 
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that leverage critical features of translation, ribosome profiling library preparation, and fragment 
alignment to more accurately detect actively translated regions of the transcriptome. 
 
Size selection during ribosome profiling library preparation typically enriches for fragments of 28-
30 nt in length.[85] Thus, an early translational scoring rubric was developed that was based on 
deviation from this expected enrichment of specific fragment lengths; this fragment length 
optimization similarity score was calculated by comparing the distribution of fragments aligned to 
a transcript against an aggregated distribution of reads aligned to all annotated protein-coding 
genes.[95] Transcripts with fragment length distributions that closely matched that of the 
aggregated reference distribution were classified as actively translated. However, because the 
scoring metric is dependent on efficient size selection during library preparation, FLOSS 
classification of translation may be sensitive to technical variations in ribosome profiling sequence 
library generation.[96] 
 
Subsequent translational classification algorithms based on analysis of ribosome profiling 
sequence data have taken advantage of additional characteristics inherent to translation and the 
alignment of RPFs to a reference transcriptome. Peptide elongation occurs through the systematic 
formation of peptidyl:tRNA bonds as amino acids are sequentially added to a nascent protein. 
Since amino acids, or codons, consist of triplet nucleotides, when ribosome profiling reads are 
aligned to a reference transcript, the A- or P-site adjust aligned position of these fragments tracks 
the tri-nucleotide codon-dependent elongation of a peptide (Figure 1.8).[95,97,98] ORFscore is a 
translational classification metric that scores the enrichment of RPFs over the canonical reading 
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frame in a transcript.[99] However, ORFscore employs a conservative scoring heuristic that 
penalizes severely for RPF enrichment outside of the canonical reading frame. Therefore, 
classification of the translational activity of transcripts based on ORFscore is less robust than other 
more recently developed algorithms.[96] 
 
More recently, translational profiling algorithms including ORF-RATER, RiboTaper, and 
SPECtre were developed; all three model the tri-nucleotide periodicity of aligned A- or P-site 
adjusted ribosome profiling reads to measure translational activity.[96,100,101] ORF-RATER 
utilizes a regression-based model to score the tri-nucleotide periodicity of aligned RPFs against a 
re-sampled transcript read coverage profile. Alternatively, RiboTaper and SPECtre directly model 
aligned and adjusted RPF coverage as a signal process, and then scores its coherence, or power 
relationship, to a reference tri-nucleotide periodic signal.[102,103] RiboTaper uses mRNA-Seq to 
build a null distribution and applies Slepian functions to normalize and score the coherence of RPF 
coverage over a transcript. In contrast, SPECtre scores the windowed (Welch’s) coherence of RPF 
coverage over a transcript against an idealized tri-nucleotide periodic signal. RiboTaper and 
SPECtre are robust to technical variations in ribosome profiling library preparation, and 
demonstrate comparable levels of sensitivity and specificity for the identification of regions in the 
transcriptome under active translation.[96] Notably, SPECtre achieves this accuracy in 
translational classification in the absence of mRNA-Seq data. 
 
1.13 Perspectives on ribosome profiling as a platform for translational discovery 
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Entrenched between transcriptional and proteomic survey methodologies, the analysis of 
ribosome-protected sequence fragments enables the surveillance of translation, and translational 
dynamics. In the proceeding chapters, we detail work that begins with the development of 
SPECtre, which measures the translational activity of regions in the transcriptome as a function of 
its tri-nucleotide periodicity. This work forms the basis for the robust detection of uORFs involved 
in the regulation of retinoic acid induced neuronal differentiation of SH-SY5Y cells. Finally, we 
extend SPECtre profiling to investigate the translational landscape of chimeric gene fusion 
breakpoints in prostate cancer. Breakpoints are identified through integrative curation of known 
fusion transcripts with de novo predictions from mRNA sequencing studies; profiling of these 
breakpoints enables the integrative characterization of chimeric gene fusion events from 
transcription to translation.  
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Figure 1.1 Gene expression and protein synthesis regulation. Genomic information encoded as 
DNA is first transcribed into RNA, then translated into protein through the multi-factorial and 
omni-directional coordination of various regulatory mechanisms. In concert, these regulatory 
mechanisms may positively or negatively regulate the abundance, function, or localization of 
protein in a cell.  
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Figure 1.2 Adjustment of RPF alignment position. Metagene profile of raw, and P-site adjusted 
ribosome profiling reads proximally aligned to canonical AUG translation initiation start sites. The 
shaded region in the plots represents the canonical coding sequence regions of the metagene 
profile. A) The raw aligned position of RPFs, often reported as the 5’ end of the aligned read to 
the reference, does not account for its physical position inside of the ribosome it was once protected 
by. Therefore, raw read coverage of RPFs is enriched upstream of the annotated meta- translation 
initiation start site of protein-coding genes. B) Following P-site adjustment of the reported RPF 
alignment positions, the meta-coverage of ribosome profiling reads on protein-coding genes is 
enriched over the annotated position of translation initiation (denoted as +0).  
 22 
 
CHAPTER 2 
Spectral profiling of uORF translation in non-differentiated and differentiated 
neuroblastoma cells 
Modified from: Chun, S.Y.*, Rodriguez, C.M.*, Todd, P.K. and Mills, R.E. (2016) SPECtre: a 
spectral coherence-based classifier of actively translated transcripts from ribosome profiling 
sequence data. BMC Bioinformatics 17(482). DOI: 10.1186/s12859-016-1355-4 
 
The work presented in this chapter of the dissertation was published in BMC Bioinformatics. Prior 
to its publication, several other algorithms were published, including those that leveraged the tri-
nucleotide periodicity of ribosome profiling alignments. Thus, multiple groups were interested in 
using similar ideas to identify regions of active translation using ribosome profiling sequence data, 
demonstrating the utility in measuring this phenomenon. Since its publication, this work has been 
cited a total of five times in the past year, further demonstrating the utility of this approach. 
Although this work is now published, much of its development was done concurrent to the work 
presented in the following chapter. Dr. Todd and Ms. Rodriguez provided experimental support, 
and Ms. Rodriguez generated preliminary ribosome profiling sequence libraries. Dr. Mills guided 
the computational approach, and I developed and implemented the coherence algorithm. 
 
 
2.1 Introduction 
 
Ribosome profiling is a next-generation sequencing strategy that enriches for ribosome-protected 
mRNA footprints indicative of active protein translation [85]. Fragments of mRNA bound by 
ribosomal complexes are selected for by enzymatic digestion, isolated using a sucrose cushion or 
gradient, released from their occupying ribosome, size selected by gel electrophoresis, and then 
sequenced. Thus, sequencing and analysis of ribosome protected fragments of mRNA enables 
profiling of the translational content of a sample on a transcriptome wide level.  
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Various algorithms have been developed to differentiate protein coding and non-coding transcripts 
in ribosome profiling sequence data using fragment length distribution differences and read frame 
enrichment of aligned reads,[95,99] However, classification based on extreme outlier analysis of 
fragment length organization similarity score differences are agnostic to the ribosome protected 
fragment abundance over a transcript. Furthermore, classification based on read frame alignment 
enrichment (ORFscore) is optimized for canonical open reading frame usage only. In addition, 
neither of the algorithms described above are available as standalone packages and must be 
implemented by the user. Published more recently, RiboTaper utilizes a coherence based approach 
to detect actively translated transcripts from the alignment of ribosome protected fragments; 
however, the RiboTaper algorithm requires matched ribosome profiling and mRNA sequence 
libraries and can take multiple days to analyze a single sample.[100]  
 
Here we introduce SPECtre, a classification algorithm based on spectral coherence to identify 
regions of active translation with high sensitivity and specificity using aligned ribosome profiling 
sequence reads without the requirement of a matched mRNA sequence library (Figure 2.1 a). 
SPECtre leverages a key feature of ribosome profiling where sequence reads aligned to a reference 
transcriptome will track the tri-nucleotide periodicity characteristic of transcripts as they are 
translated by ribosomes, and reports both significant signals of translation as well as windowed 
periodicity scores for visualizing results within a genomic context. Options to change the size of 
windows analyzed, the step size between adjacent windows, false discovery rate, abundance 
cutoffs to define actively translated versus untranslated score distributions, and parameters to 
optimize runtime performance are provided to the user to customize. Implementations of FLOSS 
and ORFscore are included with SPECtre for comparative purposes.  
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2.2 Implementation 
 
In contrast to non-coding transcripts, ribosome profiling fragments aligned to protein coding 
transcripts are characterized by a tri-nucleotide periodic signal as ribosome bound mRNAs are 
translated into protein in a codon dependent manner (Figure 2.1 b). Thus, coding transcripts may 
be differentiated from non-coding transcripts by the presence or absence of a strong tri-nucleotide 
periodic signal. To measure the strength of this tri-nucleotide signal, we calculate the spectral 
coherence over sliding N nucleotide length windows across a transcript (see also Appendix B for 
Supplemental Materials and Methods).[103] Spectral coherence is a measurement of the power 
relationship between two signals over the frequency domain, such that two signals with shared 
frequencies will have high coherence, whereas wo unrelated signals will be of low coherence. The 
SPECtre score, based on a modified Welch’s spectral density estimate of overlapping windows, is 
calculated for each transcript from a user provided transcript annotation database.[104] 
 
For a given transcript with coordinates defined by the set C, the A- or P-site adjusted read positions 
overlapping those coordinates are extracted from a BAM alignment file. The coverage over each 
coordinate in the set is summed, then normalized to the position with the highest coverage, such 
that all coordinate positions defined by the set C range from zero (no coverage) to one (highest 
coverage). The default SPECtre score is calculated as the average (Welch’s) coherence over N 
nucleotide sliding windows across a normalized coverage region against an idealized trinucleotide 
control signal of the same length. Therefore, the SPECtre score across a normalized coverage 
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region R, with coordinates C, against an idealized trinucleotide periodic signal S with frequency j, 
over adjacent N nucleotide windows is given by: 
(1) 
𝑆𝑝𝑒𝑐𝑅𝑆,𝑗 =  
1
𝑀
∑ 𝐶𝑜ℎ𝑅𝑚,𝑚+𝑁𝑆𝑁,𝑗
𝑀
𝑚=1
 𝑓𝑜𝑟 𝑎𝑙𝑙 𝑚 + 𝑁 ∈ 𝐶 
Alternatively, the number of sliding windows (Wn) over the coordinate set C, may be modified 
based on the step size between each window. Therefore, given a coordinate set C, and step size of 
L: 
(2) 
𝑊𝑛 = 𝐶𝐿𝑛, 𝑓𝑜𝑟 𝑛 ≥ 1 𝑎𝑛𝑑 𝐿 ≥ 1 
Therefore, the default SPECtre score of a normalized coverage region R, at frequency j of an 
idealized trinucleotide signal S, over N nucleotide sliding windows with a step size of L, is given 
by the equation: 
(3) 
𝑆𝑝𝑒𝑐𝑅𝑆,𝑗 =  
1
𝑀
∑ 𝐶𝑜ℎ𝑅𝑚,𝑚+𝑁𝑆𝑁,𝑗
𝑀
𝑚=1
 𝑓𝑜𝑟 𝑎𝑙𝑙 𝑚 ∈ 𝑊𝑛 𝑎𝑛𝑑 𝑎𝑙𝑙 𝑚 + 𝑁 ∈ 𝐶 
Distributions of these scores are generated using a user-defined fragments per kilobase per million 
reads cutoff to differentiate transcripts under active translation from those that are not; these 
distributions are then used to derive a minimum SPECtre score threshold for active translation 
given a pre-determined false discovery rate, as well as the posterior probability that a given 
transcript or region is actively translated.[105] 
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Ribosome profiling libraries treated with cycloheximide typically isolate RPFs of 28 to 30 
nucleotides in length; these fragments align with high fidelity to protein-coding regions. However, 
in the absence of cycloheximide, conformational changes in the ribosomal complex enrich for a 
shorter range of RPFs that also map with high fidelity to protein-coding regions.[92] Enrichment 
of these shorter-range fragments may obscure the trinucleotide signal profiled by coherence-based 
classifiers, like SPECtre, and may under-estimate the number of actively translated ORFs. We 
simulated increasing variance of RPF lengths outside of the expected enrichment of 28-30 nt length 
fragments through a biased sampling of reads aligned to the housekeeping gene ACTB. With 
increased bias, the RPF length distribution is no longer enriched in fragments of 28-30 nt in length, 
but instead progressively resembles a uniform distribution (Supplemental Figure A.1).  Biased re-
sampling of 10,000 out of over 500,000 P-site adjusted reads aligned to ACTB was performed 
over 10,000 trials, and in each trial the sampled reads were converted into normalized coverage, 
then scored by SPECtre. Using an extreme outlier cutoff, this biased re-sampling analysis suggests 
that SPECtre scoring remains robust under increased variance in sequence library fragmentation 
(Supplemental Figures A.1 and A.2). 
 
2.3 Results  
 
We assessed the sensitivity and specificity of each classification algorithm using recently 
published ribosome profiling and mRNA-Seq data derived from HEK293 cells.[100] For the 
comparative analysis of each classification algorithm in the HEK293 ribosome profiling library, 
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RiboTaper (version 1.3) was run against published read alignments using the included GENCODE 
(v19) transcript annotation database.[106] The highest scoring RiboTaper ORFs were extracted 
from the orfs_found results file using the transcript identifiers and scoring method from the 
ORFs_max output. These ORFs were then scored by SPECtre (using default parameters), FLOSS 
and ORFscore, and the relative performance of each algorithm was assessed by receiver operating 
characteristic analysis. Previous work has benchmarked classifier performance using a series of 
transcript FPKM cutoffs or other coverage based metrics [95,99,100]. Therefore, ROC analyses 
were performed using a series of ORF abundance cutoffs based on FPKM to differentiate those 
under active translation from those that are not. In this manner, we are able to assess the ability of 
each approach to identify ORFs with signatures of active translation in the interrogated cell type. 
We performed ROC analyses and calculated the AUC over pre-defined RPF abundance cutoffs 
(0.5, 1.0, 3.0, 5.0 and 10.0 FPKM) to assess the relative performance of each classification 
algorithm to accurately define regions of active translation. In HEK293 cells, SPECtre conforms 
with high fidelity to RiboTaper classification and outperforms both FLOSS and ORFscore to 
identify actively translated ORFs (Figure 2.2 a and b).  
 
We also used previously published ribosome profiling data derived from mouse embryonic stem 
cells and zebrafish embryos to assess the performance of SPECtre, FLOSS and ORFscore in the 
absence of mRNA-Seq data (Supplemental Table A.1); RiboTaper was excluded from these 
analyses due to its requirement of matched mRNA-Seq data. Ribosome profiling sequence reads 
from each set were aligned to the mouse or zebrafish reference genome and transcriptome, 
respectively. Antisense, overlapping and neighboring protein coding and non-coding transcripts 
were removed from the analysis using methods described previously [95]. The FLOSS, ORFscore 
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and SPECtre metrics were calculated for each remaining transcript and ROC analyses were carried 
out as described above. SPECtre remains robust in its classification of actively translated 
transcripts in the standalone mESC ribosome profiling library (Figure 2.2 c and Supplemental 
Table A.2), and exhibits a marked improvement in accuracy in a meta-analysis of ribosome 
profiling libraries derived from zebrafish embryos (Figure 2.2 d).  
 
A unique feature of SPECtre is its ability to report and visualize signals of periodicity in the context 
of surrounding genomic features. Graphical output from SPECtre analysis is shown for two 
representative transcripts (Figure 2.3 a and b). A condensed transcript profile of RCC1-201 
(ENST0000398598) is show in Figure 2.3(a) with the 5’UTR and 3’UTR depicted by the narrow 
black lines, and the CDS region depicted with the thicker black line. In gray is the normalized 
P-site adjusted read coverage over the transcript, with the posterior probability calculated by 
SPECtre denoted by the black line. The dashed horizontal line represents the translational 
threshold calculated by SPECtre at a false discovery rate of 0.05. In addition to the transcript 
structure depicted in Figure 2.3(b) are two upstream open reading frames detected by separately 
by RiboTaper (asterisked black bars) in the MIEF1 (ENST0000325301) transcript. Although the 
5’UTRs of both RCC1­201 and MIEF1 are profiled by RPF coverage, SPECtre analysis identifies 
only the uORFs in the 5’UTR of MIEF1, also identified previously by RiboTaper, with a 
trinucleotide signal of sufficient strength to be indicative of translational potential.[100]  
 
A further analysis of these and other ORFs assessed by both SPECtre and RiboTaper show a very 
high degree of score consistency between the two algorithms (Figure 2.3 c) in addition to their 
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comparable overall accuracy. However, SPECtre has been designed to be fast and efficient and 
exhibits a runtime almost one third of that required by RiboTaper (Figure 2.3 d) without requiring 
RNA­Seq data. This is achieved through SPECtre’s ability to chunk experiments and parallelize 
analyses over multiple threads, depending on available computational resources, which enables 
this exceedingly fast runtime relative to existing methods and decreases the computational barrier 
between library alignment to application and validation. For these experiments, SPECtre analysis 
was split by chromosome and run using 8 processors, with 32 gigabytes of RAM allocated; 
RiboTaper was run with default parameters, using 8 processors and 64 gigabytes of RAM. Both 
SPECtre, and RiboTaper were run on a high-performance computing cluster running Red Hat 
Enterprise Linux version 6.4 (Santiago). For installation simplicity and application efficiency, 
SPECtre has been written in Python with minimal third-party dependencies; the only non-standard 
Python libraries required for SPECtre analysis are RPy2, NumPy, HTSeq, SAMTools, PyFASTA, 
PySAM, and the R package ROCR.  
 
2.4 Conclusions  
 
SPECtre is a flexible, lightweight, command line driven analytical package that identifies regions 
of active translation through modeling of the tri-nucleotide periodicity characteristic of translation 
by ribosomes, and does so with high fidelity to a recently published method that relies on a similar 
coherence based approach. SPECtre classification also outperforms prevailing algorithms based 
on fragment length distribution profiling and reading frame occupancy enrichment. SPECtre is 
robust across ribosome profiling libraries derived from multiple organisms and cell types, even in 
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the absence of matching mRNA-Seq data, and is capable of identifying active translation in regions 
previously thought to be non-coding. Furthermore, SPECtre is under continuous development to 
optimize compute run time and memory overhead in order to facilitate the efficient and accurate 
investigation of translational dynamics through ribosome profiling sequence analysis. 
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Figure 2.1 SPECtre pipeline and tri-nucleotide periodicity a) SPECtre analytical pipeline, input 
files, formats and outputs. b) Ribosome profiling read coverage averaged over annotated protein 
coding transcripts demonstrates a tri-nucleotide periodic signal characteristic of translation by 
ribosomes. 
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Figure 2.2 Comparative analysis of SPECtre against previously published methods. a) 
Performance of SPECtre, RiboTaper, FLOSS and ORFscore classification of ORF translation at 
various PRF abundance cutoffs as measured by AUC in ribosome profiling of HEK293 cells.[100] 
b) ROC curves of SPECtre, RiboTaper, FLOSS, and ORFscore at a cutoff of 1.0 FPKM. c) 
Performance of SPECtre, FLOSS, and ORFscore classification of ORF translation in ribosome 
profiling of mESC at various RPF abundance cutoffs as measured by AUC.[95] d) Performance 
of SPECtre, FLOSS, and ORFscore classification of ORF translation in a meta-analysis of 
ribosome profiling in zebrafish over various RPF abundance cutoffs as measure by AUC.[99] All 
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SPECtre analyses were based on 30 nt sliding windows, using a step size of three between each 
window. 
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Figure 2.3 Examples of SPECtre results and runtime comparison to RiboTaper. a) SPECtre 
posterior probability profile (shaded gray) and normalized P-site adjusted read coverage (black 
bars) over the transcript structure of RCC1-201. Solid, horizontal black line represents the 
translational threshold as calculated by SPECtre at a false discovery rate of 0.05. Arrow indicates 
position of annotated translational start site. Thin black boxes (left to right) denote the 5’UTR and 
3’UTR, respectively, with CDS (thick black box) in between. b) SPECtre posterior probability 
profile (as above) over the transcript structure of MIEF1. Thin, black boxes under transcript 
structure denote two uORFs previously identified by RiboTaper analysis. c) Scatter plot of 
SPECtre and log2(RiboTaper) scores over assessed ORFs. d) Comparison of SPECtre (left) and 
RiboTaper (right) total compute time, in hours.
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 CHAPTER 3 
Translational profiling of uORFs in a cellular model of neuronal differentiation 
Modified from manuscript in preparation: Rodriguez, C.M.*, Chun, S.Y.*, Mills, R.E. and Todd, 
P.K. (2017) Translational profiling of uORFs in a cellular model of neuronal differentiation. 
  
The work presented in this chapter has been modified from a manuscript in preparation. The 
project context, design and scope were conceived by Dr. Todd, and Ms. Rodriguez. Ms. Rodriguez 
grew and differentiated the SH-SY5Y cells, prepared the sequencing libraries, and performed the 
biological validation experiments. Dr. Mills directed the computational approach and analyses, 
and I developed the uORF prediction pipeline, processed the data, and led the bioinformatics 
analyses. 
 
 
3.2 Introduction 
 
The development of massively parallel next-generation sequencing and application of robust 
analytical methods have empowered the quantitative characterization of the gene expression 
changes that underlie phenotypic diversity and cellular function. Corresponding advancements in 
mass spectrometry and peptide identification algorithms have made it possible to track gene 
expression from the transcriptome through the proteome.[84] However, critical differences in 
sampling, scale, and search methodologies makes linear comparison across the two platforms 
imperfect.[107] Furthermore, we have increasingly come to understand the complex regulatory 
network of interactions and changes that makes comprehensive profiling of the genome, 
transcriptome and proteome elusive. Although components of this underlying regulatory network 
may be inferred from evaluating changes in transcript abundance, translational profiling may 
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provide additional context for how these changes contribute to cellular function and 
diversity.[85,108-110] 
 
Translational regulation of protein expression drives changes affecting the state, or programming, 
of a cell under a dynamic set of conditions.[26-30] As such, profiling ribosome occupancy across 
the transcriptome under various cell states has proven a powerful platform to assess the 
relationship between mRNA abundance and its translational output to the proteome.[85,108-110] 
Early ribosome profiling experiments demonstrated the broad capacity of the technique to provide 
sensitive and condition-specific measurement of changes in mRNA translational efficiency that 
impact cellular processes from meiosis to development.[85,108-119] Furthermore, these studies 
also revealed for the widespread presence of translating ribosomes in regions outside of annotated 
protein-coding sequences.[99,108,109,120-127] In this study, we used SH-SY5Y neuroblastoma 
cells treated with retinoic acid to investigate the translational landscape that underlies their 
terminal differentiation into a population of cells that resemble neurons. While previous studies 
have investigated the genetic changes that contribute to this process, many have focused on 
transcript-level changes that may not be reflected as protein-level differences.[128,129] This work 
provides further transcriptomic and translational context for the network of protein synthesis shifts 
associated with cellular differentiation. 
 
Early ribosome profiling experiments presented evidence for the enrichment of RPFs in the 
5’UTRs of protein-coding transcripts. [99,108,109,120-126] Based on these reports, several 
computational and analytical algorithms have been developed to assess translation of these 5’ 
leader sequences, or uORFs.[95,96,99-101,130,131] These studies underscored the regulatory 
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significance of uORF translation on downstream protein-coding genes, and established their 
prevalence as translational regulators, but often lacked one of three features: 1) implementation of 
stringent parameters to identify translated uORFs, 2) inclusion of uORFs that utilize a non-
canonical TIS, and 3) investigation of a biological process that define a novel role for uORFs. In 
this study, we seek to uncover new roles for translation in the 5’ leader under various cell 
conditions apart from those already studied. Several studies have elucidated a role for uORFs in 
circadian clock regulation, zebrafish development, cell proliferation, and tumorigenesis.[99,132-
135] Moreover, as studies emerge in distinct cell-types, more multi-cistronic transcripts are 
unveiled across the genome with potential to contribute to the regulation of the proteome, but may 
be constrained to a specific set of conditions. 
 
The 5’ leader sequence in mRNA is a well-characterized source of protein synthesis 
regulation.[17] Translation of regions in the 5’ leader sequence may indirectly, or directly, regulate 
the synthesis of the canonical protein product; this can occur by altering mRNA and translation 
factor binding, influencing mRNA stability, or through the interaction of the newly synthesized 5’ 
protein product with the ribosome.[31] The translation of one of two experimentally validated 
uORFs initiated upstream of the transcriptional regulator ATF4 is dependent on the 
phosphorylation of eIF2 in response to cellular stress (Figure 1.3).[32] ATF4 is a transcription 
factor that mediates the expression of genes that mitigate cellular damage caused by conditions of 
stress.[33,34] The translation of ATF4 is governed by two ORFs: uORF1 is terminated upstream 
of ATF4 and the second ORF, uORF2, which terminates within the annotated CDS of ATF4. The 
5’ proximal uORF1 is a positive-acting cis-regulatory element that modulates ribosomal scanning 
and re-initiation of the downstream ATF4 coding sequence.[35] When eIF2-GTP is abundant 
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under normal, non-stressed conditions, scanning ribosomes downstream of uORF1 re-initiate at 
uORF2, which inhibits translation of the ATF4 protein. In stressed conditions, eIF2 is 
phosphorylated and results in a reduction of free eIF2-GTP; reduced levels of eIF2-GTP increases 
the time required for the scanning ribosomes to re-initiate translation. Thus, ribosomes 
downstream of uORF1 scan through and do not re-initiate translation of uORF2, instead translation 
is re-initiated at the ATF4 CDS which mediates the activity of downstream target genes in response 
to cellular stress.[35-37] 
 
Previous ribosome profiling studies have revealed an overall repressive role for uORFs on the 
translational efficiency of the downstream protein; however, these analyses limited their 
investigation to uORFs initiated from AUG start codons in the 5’UTR. Although translation 
initiation from non-AUG start sites remains less characterized, the prevalence and functional 
impact of non-AUG-initiated translation has been studied in certain disease-related 
contexts.[38,136,137] Furthermore, it is unknown how uORFs might contribute to protein 
synthesis regulation during neuronal differentiation. In this study, we identified 27.6% of mRNA 
transcripts contain one or more uORFs using the translational classification algorithm SPECtre 
and stringent heuristic filtering. 32.6% of the identified uORFs are predicted to use an AUG 
initiation site, with the near-cognate codon CUG being the next most abundantly used TIS. uORFs 
with AUG and near-cognate start codons can be experimentally validated, demonstrating a 
biologically founded algorithm allows for reliable annotation of these non-canonical events. We 
found that both overlapping and non-overlapping uORFs are conserved, and have increased GC 
content. Interestingly, uORF translation shifts between the non-differentiated and RA-
differentiated cell types; this is important because our data show that uORFs exert a repressive 
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effect on downstream protein synthesis based on the proximity of their termination relative to the 
annotated CDS start site. Our work expands on established observations by building a set of 
principles which may be used to determine the translatability of a 5’ leader, and its potential for 
affecting canonical protein translation, while detailing all of the translational changes associated 
with RA differentiation of SH-SY5Y cells.[129,138-140] 
 
3.3 Materials and Methods 
 
SH-SY5Y cell maintenance and differentiation  
SH-SY5Y cells were grown in DMEM:F12 media (Invitrogen) supplemented with 10% FBS, 0.01 
mg/mL Gentamicin and 0.25 µg/mL Amphotericin B. Cells were plated on 150 mm plates that 
were either coated with 0.1 mg/mL poly-D lysine (Millipore) for differentiation or uncoated. Cells 
were allowed to propagate to 80% confluency for 1-2 days prior to lysing for ribosome profiling 
or induction of differentiation. SH-SY5Y cells were differentiated for 6 days in 10 μM retinoic 
acid (all-trans, Sigma), with media changed every 24 hours prior to lysing. 
 
Construction and next-generation sequencing of ribosome profiling libraries 
Cells were washed with ice cold PBS with CHX at 100 µg/mL, flash frozen in liquid nitrogen, and 
lysed on ice (in the presence of CHX) to prevent ribosome loading and runoff. Additional lysates 
were processed in parallel for poly(A) mRNA purification and library preparation using the TruSeq 
Library Preparation Kit (Illumina). Polysomes were isolated from the ribosome foot printing 
lysates on a 1 M sucrose gradient with high speed centrifugation using a 70.1 Ti rotor (Beckman) 
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at 55,000 revolutions per minute for 4 hours at 4°C. RNA footprints were processed according to 
previously described methods.[89] rRNA was eliminated prior to linker ligation using Ribo-Zero 
Gold rRNA Removal Kit (Illumina). Ribosome profiling libraries were barcoded and multiplexed 
with 2-4 libraries per lane, and sequenced on a HiSeq 2000 (Illumina) using 50 cycles of single 
end reads. mRNA libraries were multiplexed on a single lane. All sequencing was conducted at 
the University of Michigan DNA Sequencing Core.  
 
Plasmid construction 
pcDNA 3.1 plasmid was modified to encode NanoLuc and GGG-NanoLuc as previously published 
[CITE]. gBlocks® (IDT) were ordered of the 5’ leader sequence to the last codon before the in-
frame stop of selected genes flanked by restriction sites. These were restriction cloned upstream 
of GGG-nLuc using PacI and XhoI (NEB) with 12 nucleotides between the start of the 5’ leader 
and the T7 promoter sequence to reduce spurious initiation in sequences specific to the plasmid. 
Restriction digest and Sanger sequencing were used to confirm plasmid sequence. Additional 
reporters were cloned so that the NanoLuc tag was shifted out of frame with the predicted ORF 
and the CDS start site (if present in the reporter). 
 
SH-SY5Y transfection and nanoluciferase assay 
SH-SY5Y cells were seeded on 6-well culture plates at 3x105 cells per well. 24 hours post seeding, 
each well was transfected using 7.5 μL FUGENE HD (Promega) and 1.25 μg nanoluciferase 
reporter plasmid along with pGL4.13 (internal transfection control that encodes firefly luciferase) 
were added at the same concentration in 300 μL of OptiMEM (Invitrogen). Transfections of 
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differentiated cells were performed on day 5 in RA supplemented media. Cultures were allowed 
to grow for 24 hours after transfection. Cells were lysed in 250μL Glo Lysis Buffer (Promega) for 
5 minutes at room temperature. 50 μL lysate was mixed with 50 μL prepared Nano-GLO or ONE-
Glo (Promega) for 2 minutes, and bioluminescence was detected using a GloMax®96 Microplate 
Luminometer. Nanoluciferase signal was normalized to FFluc signal in each sample. Two pcDNA 
vectors encoding nanoLuc and nanoLuc with the AUG start codon mutated to a GGG (GGG-
nanoLuc) were run in parallel with each experimental nanoluciferase plasmid and subjected to 
both conditions to serve as a control for normalization.  
 
Immunocytochemistry and microscopy  
Cells were fixed at 37°C with 4% PFA/4% sucrose in PBS with 1 mM MgCl2 and 0.1 mM CaCl2 
(PBS-MC), permeabilized for 5 minutes in 0.1% Triton-X in PBS-MC, and blocked for 1 hour 
with 5% bovine serum albumin in PBS-MC. Cells were incubated in blocking buffer and primary 
antibodies against β-actin (Santa Cruz Biotechnology, 1:1000) and neurofilament (supplier, 
1:1000) for 1 hour at room temperature. Following 3x10 minute washes in PBS-MC, cells were 
incubated in PBS-MC with Alexa Fluor 488 conjugated goat anti-rabbit IgG and Alexa Flour 635 
conjugated goat anti-mouse IgG to achieve secondary detection (Thermo Fisher, 1:1000). Cells 
were washed again, and placed in ProLong TM Gold antifade reagent with DAPI (Invitrogen). 
Imaging was performed on an inverted Olympus FV1000 laser-scanning confocal microscope 
using a 40X objective with a 1X digital zoom. Acquisition parameters were identical for each 
condition and optimized to eliminate signal bleed-through between channels. Images were 
converted to maximal-intensity z-projections in ImageJ. Cytoplasmic β-actin was quantified by 
averaging the integrated density corrected for background signal of the cells in each condition. The 
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length of one main neurofilament labeled primary neurite per cell was determined in ImageJ and 
converted from pixels to μm, and averaged for each condition.  
 
Western blotting 
Cells were maintained as described above. Cells were washed 2X in PBS, and RIPA buffer was 
added to a single well of a 12-well dish either at 80% confluency or after 6 days of retinoic acid 
differentiation. Cells were agitated for 40 minutes at 4°C to ensure complete lysis. Lysates were 
clarified by centrifugation at 15x103 RPM for 20 minutes at 4°C. The supernatant was mixed with 
reducing SDS sample buffer and boiled for 5 minutes at 90°C. Equal amounts of lysate were loaded 
on an 8% SDS-PAGE gel and subsequent western blotting was performed with primary antibodies 
against FMRP (mouse, 1:1000, 6B8, BioLegend) and GAPDH (mouse, 1:1000, Santa Cruz 
Biotechnology)—both in 5% (wt/vol) non-fat dry milk in TBS-T (NFDM). An HRP conjugated 
goat antibody to mouse IgG was used for secondary detection (1:5000, Jackson ImmunoResearch 
Laboratories) in 5% NFDM.  
 
A 12% SDS-PAGE gel was used to resolve eIF2α and ATF4. Antibody for phosphorylated-eIF2α 
(rabbit, Thermo Fisher) was used at 1:500, after secondary detection blots were stripped in a low 
pH glycine buffer and re-probed with antibody against total eIF2α (rabbit, Cell Signaling 
Technology, 1:1000) and E7 tubulin (mouse, DSHB,1:1000). Blots were stripped again and probed 
for ATF4 (rabbit, Cell Signaling Technology, 1:1000). Secondary detection was achieved using 
HRP conjugated goat antibodies to rabbit IgG or to mouse IgG in 5% NFDM (1:5000, Jackson 
ImmunoResearch Laboratories). 
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Pre-processing and alignment of mRNA and ribosome profiling sequence libraries 
Ribosome profiling and mRNA-Seq reads were trimmed of adapters, and then by quality using 
fastq-mcf from the ea-utils package (https://github.com/ExpressionAnalysis/ea-utils). Ribosome 
profiling and mRNA-Seq reads in FASTQ format were trimmed based on quality if four 
consecutive nucleotides were observed with Phred scores of 10 or below. The minimum read 
length required after trimming was 25 nucleotides. Trimmed sequences were then aligned to a 
ribosomal RNA sequence index using Bowtie v1.1.2 to deplete them of contaminant 
sequences.[62] Alignment to the rRNA sequence contaminant index was performed using the 
following parameters: seed alignment length of 22 nucleotides, no mismatches in the seed 
alignment were allowed, with the unmapped reads written to a separate FASTQ file.  
 
Calculation of translation efficiency 
Ribosome profiling or mRNA-Seq reads were counted over each region (5’UTR, CDS, and 
3’UTR), transcript, or upstream-initiated ORF and then normalized to length and library size as 
transcripts per million.[68] To calculate translational efficiency over a region, transcript or 
upstream-initiated ORF, ribosome profiling TPM in each biological replicate across each condition 
was quantile normalized and then divided by the quantile normalized TPM in mRNA-Seq.[141] 
Read and RPF counts from mRNA-Seq and ribosome profiling libraries does not include those 
that overlap the 5’UTR and 3’UTR. Furthermore, to limit the boundary effects due to translation 
initiation and termination, RPF and read counts do not include those whose A- or P-site adjusted 
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position for harringtonine and cycloheximide libraries, respectively, overlap the first or last 15 
nucleotides of an annotated CDS. 
 
Differential expression analysis and gene set enrichment testing in mRNA-Seq 
As described previously, the read abundance over annotated protein-coding transcripts was 
calculated as TPM, then quantile normalized across conditions using the preprocessCore package 
in R, and then ranked.[142] The change in rank for each gene was calculated across the non-
differentiated and RA-differentiated conditions, and the significance of the up- or down-regulation 
of these rang-changes across conditions was classified using an extreme outlier cutoff.[143] 
Functional characterization of these significantly rank-changed genes across the non-differentiated 
and RA-differentiated conditions was analyzed using the goseq package in R, and corrected for 
multiple testing using Benjamini-Hochberg adjusted p-values.[144,145] 
 
Differential translation analysis and gene set enrichment testing in ribosome profiling 
Ribosome profiling read fragments were A- or P-site adjusted, and then counted over annotated 
protein-coding CDS regions in each biological replicate using the metagene profiles generated by 
Plastid.[93] As described previously, ribosome-protected fragments with A- or P-site adjusted 
positions that overlapped the first or last 15 nucleotides of the boundaries defined by the annotated 
CDS region were masked from the analysis. DESeq2 was used to identify those genes with 
differential translation across the two states of cellular differentiation.[71] Genes were annotated 
as significantly up- or down-regulated using a Benjamini-Hochberg adjusted p-value cutoff of 0.1, 
and fold-change in counts greater than 1, or less than 1, respectively. Functional characterization 
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of these significantly up- and down-regulated genes was analyzed by goseq using parameters 
specified previously. 
 
Differential translation efficiency and gene set enrichment testing in ribosome profiling 
For each biological replicate, ribosome profiling read fragments were A- or P-site adjusted, and 
then counted over annotated protein-coding CDS regions using the metagene profiles generated 
by Plastid. As above, read counts over the first and last 15 nucleotides of protein-coding CDS 
regions were masked for subsequent analyses. In addition, mRNA-Seq read counts were extracted 
from each condition, with the proximal and terminal 15 nucleotide ends of the CDS masked for 
consistency with the RPF counts. The DESeq2 wrapper for differential translational efficiency 
analysis, was used to identify those genes with significant changes in translational efficiency.[146] 
Genes were annotated as significantly up- or down-regulated using a Benjamini-Hochberg 
adjusted p-value cutoff of 0.1, and absolute fold-change of 1. Functional characterization of the 
sets of genes enriched in each condition by translational efficiency was analyzed by goseq using 
parameters described previously. 
 
Percent change in transcript abundance 
In addition to significance cutoffs for up- and down-regulated regions or transcripts based on 
mRNA-Seq and ribosome profiling sequence alignments, global changes were assessed by percent 
change in abundance. TPM based on mRNA-Seq and RPF alignments were calculated, quantile 
normalized, and then compared by percent change in abundance across the non-differentiated and 
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RA-differentiated libraries. The number of genes with a change in TPM across the two conditions 
was evaluated at pre-defined percent-change cutoffs of 10%, 20%, 30%, 40% and 50%. 
 
Conservation and GC nucleotide content analysis 
To assess the conservation of the various regions, transcripts and ORFs, the PhyloCSF over each 
target region was extracted.[147] For upstream-initiated ORFs, the PhyloCSF score was extracted 
according to its predicted phase. In order to de-convolute the contribution of regional conservation 
due to overlap with annotated CDS regions, predicted ORFs that did not initiate and terminate 
wholly upstream of a CDS were also scored according to the subset of their coordinates defined 
by the 5’UTR alone. The mean PhyloCSF over each of these regions and ORFs was calculated, 
and then mean-shifted to canonical (+0) reading frame of the annotated CDS for comparison. The 
G/C nucleotide content of each region was calculated as the number of G and C nucleotides in a 
given region divided by its length. The G/C nucleotide content was calculated for annotated 
5’UTRs, CDS, 3’UTRs and over each predicted ORF; the G/C content for the 5’UTR portion of 
ORFs predicted to terminate in the CDS was calculated separately. 
 
Cluster analysis of differential uORF translation by SPECtre score 
In order to identify subsets of upstream-initiated ORFs with differential translation in one state of 
cell differentiation compared to the other, the SPECtre score for each predicted ORF was 
calculated (see Appendix B). The SPECtre score of each predicted ORF was classified by k-means 
clustering in R to define sets of uORFs with differential translation in one of the conditions, and 
those with no difference in translational potential between the two conditions. 
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Kernel density estimation of differential uORF regulation on CDS translation efficiency 
To further differentiate those uORFs with differential translation and identify those that contribute 
to the regulation of downstream CDS, the log-change in predicted ORF TPM was compared 
against the log-change in downstream CDS TPM across the conditions. The differential 
translational identity of each predicted ORF was retained from the SPECtre clustering analysis, 
and kernel density estimation was performed using R. 
 
Multiple regression analysis of uORF regulation on CDS translation efficiency 
In order to assess the global contribution of uORFs and oORFs on the change in translational 
efficiency of the downstream CDS, a multiple regression model was built using: the change in 
abundance (in TPM) over each predicted ORF across conditions (delta_tpm), the GC content over 
each predicted ORF restricted to the portion of each ORF overlapping the 5’UTR (gc), the 
PhyloCSF conservation score over the predicted ORF restricted to the part of each ORF 
overlapping the 5’UTR (cons), the proximity of the termination site defined by each ORF as its 
absolute distance, in nucleotides, to the annotated CDS translation initiation site (dist), and the 
binary classification of the predicted translation initiation site, as AUG-initiated or non-AUG-
initiated, for each ORF (tis). Each of the above parameters was input as a prediction variable, with 
the change in translational efficiency of the CDS across the RA-differentiated and non-
differentiated states as the outcome variable, using the linear model function in R. Pairwise 
interactions between the prediction variables were also tested. 
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Gene set enrichment testing of multiple regression negative residuals 
Residuals for genes tested in the multiple regression model were extracted and ranked according 
to their magnitude; genes were extracted based on their rank in the top 5th, the top 10th, and the 
top 25th percentile of negative residuals. These residual sets were then tested for gene set 
enrichment using the goseq package in R, and the p-values were corrected for multiple testing 
(Benjamini-Hochberg). The union of all gene sets across the three percentile residual sets tested 
was compiled, and the adjusted p-values in each test was tabulated for visualization. 
 
Regression analysis of uORF proximity on CDS translation efficiency 
To investigate the relationship between the proximity of upstream-initiated ORFs and the 
translational efficiency of the downstream CDS, a linear regression model was built using the 
SPECtre score of the predicted ORF as the prediction variable and the translational efficiency of 
the CDS as the dependent variable. To assess the relative contribution of proximity, predicted 
ORFs were binned according to their termination position relative to the annotated CDS translation 
initiation site. Predicted ORFs were binned every 30 nucleotides based on their termination 
position relative to the annotated CDS start site, with maximum bins limited to 300 nucleotides 
upstream, and 600 nucleotides downstream of the annotated CDS translation initiation sequence 
position. Based on the predicted ORFs terminated in each bin, the regression coefficient in each 
biological replicate over each state of differentiation was calculated. 
 
3.4 Results 
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Molecular and bioinformatic validation of retinoic acid induced differentiation of SH-SY5Y cells 
SH-SY5Y neuroblastoma cells were induced to undergo neuron-like differentiation by treatment 
with retinoic acid (Figure 3.1A); efficacy of RA-induced differentiation was assessed by 
immunocytochemistry staining using neuron-specific markers. Neurofilament staining is more 
prominent in RA-differentiated SH-SY5Y cells (Figure 3.1B, left) than in non-differentiated cells. 
In addition, each main neurite was selected and analyzed for neurofilament staining and length; 
neurites in RA-differentiated cells are longer than in non-differentiated cells (Figure 3.1D). 
Furthermore, beta-actin staining is more diffuse in non-differentiated cells compared to the 
punctate staining observed in RA-differentiated cells (Figure 3.1A, left middle). Individual cell 
fluorescence measurements confirmed the higher staining of non-differentiated cells by beta-actin 
(Figure 3.1D). Finally, the post-synaptic marker FMRP was detected by Western blot, and enriched 
in RA-differentiated cells compared to non-differentiated cells (Figure 3.1E and F). In sum, the 
RA differentiated cells displayed characteristics phenotypically consistent with post-mitotic 
neuron-like cells. 
 
Differential expression analysis and gene set enrichment testing of sequenced mRNA transcript 
abundance was used to further confirm the neuron-like differentiation of SH-SY5Y cells by 
retinoic acid. Based on the rank-change in abundance, calculated as TPM, across the two cell 
conditions (Figure 3.1G), significantly up- and down-regulated gene sets were identified in the 
RA-differentiated mRNA-Seq libraries. Significantly up-regulated gene sets in the RA-
differentiated condition included those terms related to cell communication, signaling and stimulus 
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response (Figure 3.1H). In contrast, significantly down-regulated gene sets in the RA-
differentiated state included those related to mitosis, cellular division and regulation of the cell 
cycle (Figure 3.1I). Enriched terms related to molecular function and cellular components based 
on rank-change analysis of mRNA abundance are shown in Supplemental Figures B.1 and B.2, 
respectively. Taken together, experimental validation and bioinformatic analysis confirms the 
retinoic acid induction of SH-SY5Y cells into a differentiated state phenotypically consistent with 
neuron-like cells. 
 
Integrative analysis of mRNA and ribosome profiling sequence data was used to further 
characterize the RA-differentiated and non-differentiated SH-SY5Y cells. Ribosome-protected 
fragments over each transcript were counted and differential abundance was assessed by DESeq2 
(Figure 3.2A). Significantly up- and down-regulated genes were identified, and gene set 
enrichment testing was performed (Supplemental Figures B.3 and B.4). In order to account for the 
influence of transcriptional regulation on translational abundance, we performed an additional set 
of differential analyses using translational efficiency (Figure 3.2B). Significantly up-regulated 
gene sets identified by differential translational efficiency analysis included those related to protein 
targeting and localization (Figure 3.2C). Enriched terms related to molecular function and cellular 
components based on differential translational efficiency analysis are shown in Supplemental 
Figures B.5 and B6, respectively. A representative transcript with differential translational 
efficiency across the two conditions is the axon guidance gene PLXNA2 (Figure 3.2D); PLXNA2 
is abundantly transcribed in both conditions (top and bottom, gray bars), but limited in the 
abundance of RPFs in the non-differentiated condition (top) compared to the RA differentiated 
state (bottom). Similar to the differential mRNA analysis, significantly down-regulated gene sets 
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identified by differential translational efficiency analysis (Figure 3.2E) include those related to 
mitosis, cell division, and cell cycle control. The gene TFPI2 is less efficiently translated in the 
RA-differentiated state (bottom) compared to the non-differentiated cell condition (top). Globally, 
we observe shifts in transcription and translation across the two cell conditions in a majority of 
transcripts profiled by both mRNA-Seq and ribosome profiling (Figure 3.2G). Based on these 
observations, we find global changes in transcription and translational efficiency consistent with 
RA-induced differentiation of SH-SY5Y cells in genes related to signaling, regulation of the cell 
cycle, including subsets of genes related to neuronal modeling. 
 
uORF prediction and filtering statistics 
uORFs were computationally predicted from annotated 5’UTRs of protein-coding transcripts; 
translation initiation was permitted to utilize both AUG and non-AUG near-cognate sites, where 
near-cognate sites differ from the canonical AUG initiation site sequence by one nucleotide. RPF 
coverage over the predicted uORFs was normalized, then scored by SPECtre for translational 
potential, and then filtered according to a series of heuristics (Figure 3.3). These included 
minimum RPF coverage in the 5’ leader region of the predicted uORF, removal of in-frame N-
terminal extensions, and minimum mRNA-Seq coverage in the annotated CDS region. Minimum 
mRNA-Seq coverage in the CDS was required for subsequent translational efficiency comparisons 
across the two cell conditions. In addition, redundant isoforms were converged, and overlapping 
ORFs were prioritized based on optimal RPF coverage and SPECtre score. 
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Based on the filtered set of uORFs, we identified roughly 3,100 genes with at least one predicted 
uORF (Figure 3.4A); of these, approximately 360 of these genes harbored both an overlapping 
ORF and an ORF terminated upstream in the 5’UTR (Figure 3.4B). The filtered set of predicted 
uORFs initiate proximally to the annotated protein-coding translational start site (Figure 3.4B), 
and tend to be short in length (Figure 3.4C). We next examined the sequence characteristics of the 
predicted uORFs through measurement of their G/C nucleotide content. For comparison, we found 
that annotated 5’UTRs were significantly enriched in G/C content over both CDS regions, and 
3’UTRs (Figure 3.4D). Furthermore, annotated 5’UTRs with a predicted uORF were significantly 
higher in G/C content than 5’UTRs without a predicted uORF; this is suggestive of a sequence-
based context in the 5’UTR for the efficient translation of uORFs (Figure 3.4E). However, 
upstream-terminated ORFs and the full sequence of oORFs had G/C nucleotide content that 
resembled 5’UTRs that were not predicted to have uORF (Figure 3.4F). Interestingly, when the 
CDS region of these overlapping ORFs were partitioned and the portion of these uORFs contained 
in the 5’UTR were measured, their G/C content resembled that of the 5’UTRs predicted to have a 
uORF. Although uORFs tend to resemble the 5’UTR sequences from which they are derived, these 
results are not immediately suggestive of a sequence-level difference that distinguishes them from 
their flanking 5’UTR sequence context.  
 
Translation initiation site annotation 
Given the preference for translation initiation using AUG sites, the translation initiation sites of 
predicted ORFs were re-annotated based on the proximity or presence of an in-frame AUG site. 
Based on this re-annotation, AUG and putative AUG initiation sites were the most commonly used 
start codons in the predicted ORFs (Figure 3.5A). Approximately 32.6% of predicted uORFs 
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utilized an AUG start codon, with CUG the next most common site used (16.2%). These results 
support previous reports of the preferential initiation of translation from AUG codons. Moreover, 
CUG is identified as the next most common start site, which is consistent with previous reports, 
and biochemically-validated models that suggest translation initiation from CUG sites are second 
in efficiency only to AUG start codons.[109,148] 
 
Validation of uORF translation 
A subset of transcripts with predicted uORFs were selected for experimental validation, including 
HAND2 and ARF4 (Figure 3.5B and C). Initial assessment of the translatability and regulatory 
impact of predicted ORFs was done using a nano-Luciferase reporter construct (Figure 3.5D). 
Predicted uORF sequences were inserted in-frame to an nLuc reporter with the AUG translation 
initiation site converted to a GGG; translation of the nLuc reporter would be driven by the sequence 
context provided by the 5’ leader. In addition to HAND2 and ARF4, the set of genes selected for 
validation included LAMB1, TSC1, and the leptin receptor gene, LEPR (Figure 3.5E). Two 5’ 
leader sequences from genes not thought to have highly translated uORFs were included for 
analysis as well (Figure 3.5F, black). Compared to the 5’ leader-less control construct, the 5’ leader 
sequence of all candidates tested with highly translated predicted uORFs (Figure 3.5E) drove 
expression of the nLuc reporter (Figure 3.5F, green). In addition, Western blotting confirmed the 
presence of highly translated products from the predicted uORF in LEPR, PCBD, QDPR and 
ATP5I (Figure 3.5G). Finally, we assessed the frame specificity of the predicted uORFs by shifting 
the nLuc reporter out-of-frame of the 5’ leader (Figure 3.5H). Taken together, these results validate 
the translation of predicted uORF leader sequences in an in vivo system. 
 54 
 
 
Global landscape of uORF translation on protein synthesis regulation 
To investigate the potential regulatory impact of uORF translation on a global scale within the 
context of neuronal differentiation, we identified subsets of genes with differential translation in 
the non-differentiated and RA-differentiated conditions (Figure 3.6A). SPECtre scores over the 
CDS of protein-coding transcripts were clustered into groups that were enriched in non-
differentiated cells (gold), enriched in the RA-differentiated cells (cyan), or similarly translated in 
both states (gray). Next, we coupled these translated CDS to their predicted uORFs (Figure 3.6B) 
and observed no defined relationship between uORF translation and CDS regulation. As denoted 
by the density of transcripts both above and below the line, uORF translation alone was not 
predictive of downstream CDS translation. Annotation of a predicted uORF in the 5’ leader of an 
mRNA was also not predictive of CDS regulation in both non-differentiated and RA-differentiated 
specific transcripts (Figure 3.6E, F and G). However, we do observe localized examples where 
uORF translation is sufficient to negatively impact the translation of the downstream protein 
(Figure 3.6H and I). Although the mere presence of a uORF is not predictive of translational 
repression, we identified sets of translationally repressed genes with predicted uORFs in both non-
differentiated and RA-differentiated cells. Furthermore, we identified and experimentally 
validated subsets of these uORFs that conditionally repress synthesis of the downstream protein-
coding gene in a state-dependent manner, including the leptin receptor gene LEPR. The putative 
uORF-mediated translational regulation of the leptin receptor gene in neuronal cells invites further 
scrutiny. Leptin is a hormone related to signaling of appetite satiety; the leptin receptor is involved 
in the regulation of glucose homeostasis through neuronal inhibition in the parabrachial 
nucleus.[149-151] 
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Sequence and proximity as contexts for uORF regulation 
Since prediction of a uORF and its translation were not predictive of protein synthesis regulation, 
we explored other sequence and physical components of the predicted uORFs that might be 
predictive of their regulatory impact. To this end, we built a multiple regression model based on 
the GC content of the 5’ leader region of predicted ORFs, their conservation, change in 
translational efficiency over the two conditions, TIS sequence, and the proximity of the termination 
site of the uORF to the annotated CDS (Figure 3.7A). We observed that proximity of termination 
to the annotated CDS, GC content, change in uORF translation, and conservation were all 
significant predictors of downstream CDS translation whereas the identity of the predicted TIS 
had little predictive power (Figure 3.7A and D). Furthermore, we extracted the set of genes that 
most negatively influence the regression model and found that they were enriched for biological 
processes related to cell cycle regulation, cell division and chromosome structure (Figure 3.7B). 
The full cohort of genes, with positive and negative residuals, is listed in Supplemental Table B.2. 
We decided to examine the impact of termination proximity further and built proximity-dependent 
regression models using the SPECtre score of the predicted uORFs. Based on this model, we found 
that termination proximity, in particular those uORFs that terminated inside the annotated CDS 
region, had profound effect on the downstream translation of the canonically-encoded protein 
(Figure 3.7C). Taken together, these results provide additional support for a steric hindrance model 
for translational regulation of protein synthesis by upstream open-reading frames. 
 
3.5 Discussion 
 56 
 
 
Comprehensive characterization of the diverse network of regulatory control that mediates protein 
synthesis remains elusive; however, advances in the integrative analysis of multi-scalar next-
generation sequencing data are driving increasingly sensitive insight and dissection of these 
regulatory factors that control the efficiency of protein synthesis. Translation of upstream-initiated 
open-reading frames has been well studied in various systems and organisms, and much effort has 
been made to catalog and characterize the prevalence and impact of these ORFs.[152] In this study, 
we investigated the landscape of uORF translation in a cellular model of neuronal differentiation 
and examined the significance of their regulatory potential on the synthesis of proteins relevant to 
this change in cell state. We found that upon the retinoic-acid induced conversion of SH-SY5Y 
cells into a terminally differentiated state, pathways relevant to signaling and neuronal function 
were up-regulated, and gene networks related to cell cycle regulation and division were down-
regulated. This was confirmed experimentally through immunocytochemistry, and across multiple 
scales of next-generation sequencing data; changes in gene set enrichment related to the terminal 
differentiation of SH-SY5Y cells were consistent through transcriptomic and translational 
profiling. 
 
We established a rigorous framework for the computational prediction of uORFs, and 
characterized their potential significance in the regulation of cell differentiation. Like previous 
studies, we found that predicted uORFs were concomitantly less conserved than protein-coding 
CDS regions, but more highly conserved than the background regional context of 5’ untranslated 
regions. A limited subset of protein-coding genes with translational evidence harbored a predicted 
ORF; approximately 31% of annotated protein-coding transcripts were predicted to have a 
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potentially translated uORF. Similar to earlier studies, most of these uORFs were predicted to 
initiate translation from canonical AUG start sites, with CUG translation initiation sites being the 
next most commonly utilized sequence moiety. To further disentangle the potential role of these 
uORFs in the regulation of canonical protein synthesis, we characterized global changes in the 
translational activity of protein-coding genes; we found subsets of genes that were differentially 
regulated corresponding to cellular state using spectral classification and transcript abundance 
metrics.  
 
Initial efforts to classify the regulatory significance of predicted ORFs based on their translational 
activity alone were inconclusive; although we validated the translational activity of specific 5’ 
leader sequences, only a limited subset of these were experimentally observed to regulate their 
downstream protein-coding CDS as computationally predicted. Based on these results, we 
examined additional factors that might more accurately predict the regulatory potential of these 
uORFs. We built a multiple regression model that accounted for the translational activity of the 
predicted uORFs, as well as their conservation status and sequence context. Furthermore, we 
accounted for their predicted initiation site identity, and their spatial proximity to the annotated 
protein-coding start site. Based on this multiple regression model, we found that all of these factors 
except initiation site identity were significant predictors of changes in the translational efficiency 
of the annotated protein-coding CDS. Among the genes that were most translationally suppressed 
upon terminal differentiation of SH-SY5Y cells were those related to regulation of the cell cycle, 
cell division, and chromosome organization. Indeed, we found that the spatial proximity of the 
predicted uORFs contributed significantly to their translational regulation of protein-coding CDS. 
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Taken together, we find that a subset of uORFs negatively regulate the translation of their 
downstream protein-coding CDS; furthermore, the conservation of these ORFs, their GC 
nucleotide content, translational activity, and their spatial proximity to the annotated CDS 
contribute significantly to their regulatory potential. Translation of many of these uORFs results 
in the suppression of genes related to the cell cycle and cellular division; pathways that are down-
regulated upon retinoic acid differentiation of SH-SY5Y cells. These results contribute additional 
evidence for the importance of uORF translation in the control of protein synthesis, and suggest 
additional factors that may mediate their regulatory potential within the context of a cellular model 
of neuronal differentiation. 
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Figure 3.1 Retinoic acid treatment induces neuronal differentiation of SH-SY5Y cells. A) 
Schematic of the experimental design and the basic workflow for data acquisition. B) 
Immunocytochemistry performed on non-differentiated and RA-differentiated SH-SY5Y cells 
confirmed the shift to a neuronal phenotype with RA treatment. Cells of both conditions were fixed 
and stained with antibodies against neurofilament (red), and beta-actin (green), and nuclei were 
DAPI stained (blue). C) Individual cell fluorescence was quantified and represented as corrected 
total cell fluorescence for beta-actin; n=119 for non-differentiated and n=118 for RA-
differentiated. D) Each main neurite was selected and analyzed for neurofilament staining and 
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length; n=109 for non-differentiated and n=100 for RA-differentiated. E) Western blotting of both 
cell conditions showed an increase in the post-synaptic marker FMRP in the RA-differentiated 
cells, and quantified in F); n=4 for both conditions. For panels C), D), and F) Student’s T-test p-
value<=0.0001. Graphs represent mean ± S.E.M. G) Differential mRNA abundance based on non-
differentiated versus RA-differentiated transcripts per million. Transcripts were defined as 
significantly up-regulated (cyan) or down-regulated (gold) in the RA-differentiated cell condition 
based on rank-change in TPM compared to the non-differentiated condition. H) Significantly 
enriched up-regulated gene sets in RA-differentiated mRNAs based on Benjamini-Hochberg 
multiple testing corrected p-values. Black vertical line in panels H) and I) denotes a corrected p-
value cutoff of 0.05. I) Significantly enriched down-regulated gene sets in RA-differentiated 
mRNAs based on Benjamini-Hochberg multiple testing corrected p-values.  
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Figure 3.2 Differential translation and translational efficiency in SH-SY5Y cells. A) Volcano plot 
of transcripts with differential translation by ribosome-protected fragment counts in non-
differentiated and RA-differentiated cells. Significantly up-regulated (cyan) and down-regulated 
(gold) genes in RA-differentiated cells are defined by a log2-normalized fold-change cutoff of ±1 
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(vertical lines), and a multiple testing corrected p-value cutoff of 0.1 (horizontal line). B) Volcano 
plot of transcripts with differential translational efficiency by Riborex analysis in non-
differentiated and RA-differentiated cells. Significantly up-regulated (cyan) and down-regulated 
(gold) genes in RA-differentiated cells are defined by a log2-normalized fold-change cutoff of ±1 
(vertical lines), and a multiple testing corrected p-value cutoff of 0.1 (horizontal line). C) Gene 
sets with significantly up-regulated translational efficiency in RA-differentiated cells. The top five 
biological processes with significant enrichment using a multiple testing p-value cutoff of 0.05 
(vertical line) include those terms related to cell division, and the regulation of the cell cycle. D) 
Normalized mRNA (gray) and RPF coverage (red) over the 5’UTR (thin line, left), CDS (thick 
line, middle), and 3’UTR (thin line, right) of the axon guidance gene, PLXNA2, is representative 
of a transcript with higher translational efficiency in the RA-differentiated cell condition. E) Gene 
sets with significantly down-regulated translational efficiency in RA-differentiated cells. The top 
five biological processes, using a multiple testing p-value cutoff of 0.05 (vertical line) include 
terms related to protein target, and localization. F) Transcript coverage plot of TFP12 demonstrates 
higher coverage by RPFs (red) relative to mRNA (gray) in the non-differentiated cell condition. 
G) Genes that change in RPF abundance as measured by mRNA-Seq and ribosome profiling. Pre-
defined cutoffs in percent change of TPM across the two cell conditions was evaluated by mRNA 
and RPF abundance, and the number of genes that changed as measured by one, both, or neither 
was counted. 
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Figure 3.3 Computational prediction and filtering of ORFs. ORFs were predicted from AUG and 
non-AUG near-cognate translation initiation sites in the 5’UTR of annotated protein-coding genes, 
and computationally extended to the first in-frame termination site encountered in the 5’UTR 
(upstream-terminated ORFs) or CDS (overlapping ORFs). Predicted ORFs were then filtered 
according to a series of heuristic filters including: minimum RPF coverage in the 5’UTR, 2) in-
frame N-terminal extensions, 3) redundant isoforms, 4) minimum length, 5) sufficient SPECtre 
signal, and 6) those CDS with no mRNA-Seq coverage to be tested for translational efficiency. 
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Figure 3.4 Characterization of predicted ORFs. A) The number of genes with at least one predicted 
ORF (bar plot) in the 5’UTR of evaluated protein-coding genes. Breakdown of the number of 
genes with a predicted ORF terminated upstream in the 5’UTR only (left circle), terminated in the 
CDS only (right circle), or with both a predicted upstream-terminated and CDS-overlapping ORF 
(overlap). B) Distribution of predicted ORF translation initiation relative to the annotated protein-
coding CDS start site in non-differentiated specific genes (gold), RA-differentiated specific genes 
(cyan), and in aggregate (gray). Distribution of predicted ORF lengths in non-differentiated 
specific genes (gold), RA-differentiated specific genes (cyan), and in aggregate (gray). D) GC 
nucleotide content in annotated transcript 5’UTRs (dark gray), CDS (blue), and 3’UTRs (light 
gray). E) GC nucleotide in annotated 5’UTRs with a predicted ORF (dark gray), and those 5’UTRs 
without a predicted ORF (light gray). F) GC nucleotide content of predicted upstream-terminated 
ORFs (red), overlapping CDS-terminated ORFs (light orange), and the 5’UTR specific portion of 
predicted CDS-terminated ORFs (dark orange). 
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Figure 3.5 Validation of SPECtre scored uORFs. A) Distribution of predicted ORF translation 
start site sequences. Near-cognate start codons are utilized in the majority of predicted ORFs. AUG 
is the single most common initiation codon; this was either directly identified by SPECtre (AUG), 
present within 30 nucleotides upstream of the start of the SPECtre signal without an intervening 
stop site (AUG*), or located greater than 30 nucleotides upstream of the start of the SPECtre signal 
without an intervening stop codon (AUG+). Due to the high translatability of an ORF with an 
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AUG start codon, these were annotated as putatively AUG-initiated events. B) and C) Plots show 
mRNA read coverage (gray), and RPFs (red). B) HAND2 is a transcript with 4 predicted upstream-
initiated ORFs. C) ARF4 is a transcript with one predicted upstream-terminated ORF, and one 
CDS-overlapping ORF with condition-dependent translation. D) Schematic of the uORF 
nanoluciferase (nLuc) reporters used in this study. GGG-nLuc serves as a negative control, as its 
AUG initiation start codon is mutated to a GGG codon. This reporter supports very little 
translation. E) A table of the predicted start sites for each uORF reporter from the high confidence 
dataset. F) nLuc assays performed in SH-SY5Y cells confirmed expression of high confidence 
uORFs (purple). 5’ leaders not included in the high-confidence dataset (black) are below the GGG-
nLuc reporter activity and considered not translated. All values are normalized to the GGG-nLuc 
control performed in parallel during experimentation, data for individual reporters was collected 
in triplicate in multiple experiments. G) Western blotting confirmed protein production of the 
highly translated ORFs. H) Reporters were cloned so that the nLuc tag was shifted out of frame 
(f.s.) with the predicted ORF and the CDS start site (if present in the reporter). This lead to a 
significant decrease in reporter signal and confirmed frame specificity of our detection algorithm. 
n=3 for all experiments. **** denotes a Student’s T-test p≤0.0001. All green ORFs in panel F) 
have a p-value ≤0.0001, and all black ORFs have a p-value <0.05. Graphs represent mean ± S.E.M.  
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Figure 3.6 Translational efficiency of CDS with predicted uORFs. A) K-means clustering analysis 
of protein-coding CDS translational potential as score by SPECtre with predicted upstream-
initiated ORFs in non-differentiated and RA-differentiated cells. Three clusters of CDS regulation 
emerge: those CDS that are up-regulated in RA-differentiated cells (cyan), up-regulated in non-
differentiated cells (gold), and CDS with no change in translational potential (gray). B) Kernel 
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density estimation analysis of changes in TPM over annotated protein-coding CDS as a function 
of changes in TPM over predicted upstream-initiated ORFs. Cluster identity of predicted ORF 
changed in translational potential as scored by SPECtre is identical to panel A): predicted ORFs 
enriched for translation in RA-differentiated cells (cyan), predicted ORFs with enriched translation 
in non-differentiated cells (gold), and those with static translation across the two conditions (black, 
for visibility) are annotated to protein-coding CDS with higher RPF abundance in non-
differentiated cells (above horizontal line), and those with higher RPF abundance in RA-
differentiated cells (below horizontal line). C) Western blotting for GADD34 levels in non-
differentiated and RA-differentiated cells showed a decrease with differentiation. This is opposite 
GADD34 ORF translation, which falls into the cluster of higher translation in the RA-
differentiated condition A). D) Empirical cumulative distribution of translational efficiency in all 
protein-coding CDS across RA-differentiated (cyan) and non-differentiated cells (gold). E) 
Empirical cumulative distribution of protein-coding CDS with a predicted upstream-initiated ORF 
(gold) and those CDS without a predicted ORF in non-differentiated cells. F) Empirical cumulative 
distribution of protein-coding CDS with a predicted upstream-initiated ORF (cyan) and those CDS 
without a predicted ORF in RA-differentiated cells. G) Percent of genes with a predicted upstream-
initiated ORF with higher translational efficiency in RA-differentiated cells (orange), lower 
translational efficiency in RA-differentiated cells (green), or no change in translational efficiency 
between RA-differentiated cells and non-differentiated cells (gray). H) nLuc assays of the 
specified ORF reporters transfected in both non-differentiated and RA-differentiated cells 
confirmed a shift in translation as predicted by SPECtre. n=3 for each condition in panel H). * 
denotes a Student’s T-test p≤0.05 and **** p≤0.0001. Graphs represent mean ± S.E.M.  
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Figure 3.7 Characterization of predicted uORF regulation and downstream CDS. A) Significance 
of prediction variables in multiple regression model of protein-coding CDS translation regulation. 
Absolute distance of the predicted ORF position (dist), GC content of the 5’ annotated region of 
predicted ORFs (gc), change in TPM over predicted ORFs (delta_tpm), and conservation of the 5’ 
annotated region of ORFs (cons) are significant predictors of changes in CDS translation 
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(horizontal line denotes a significance value cutoff of 0.05), whereas translation initiation site 
identity of the predicted ORF (tis) is not a significant predictor. B) Gene set enrichment testing of 
the 5th, 10th and 25th percentile of genes with negative residuals in the multiple regression model. 
Gene sets are considered as significantly enriched using a multiple testing corrected p-value cutoff 
of 0.05 (white), with highly significant enriched terms in red. C) Linear regression model of 
protein-coding CDS translational efficiency as a function of predicted ORF SPECtre score and 
proximity of ORF termination to annotated CDS start site. Boxes are comprised of the linear 
regression coefficient in both biological replicates in non-differentiated and RA-differentiated 
cells, with the mean regression coefficient of all four replicates denoted by a black bar. Dashed 
horizontal line denotes a linear regression coefficient of zero. D) Empirical cumulative distribution 
of protein-coding CDS with upstream-initiated ORFs with a predicted AUG translation initiation 
start site (solid line), and those predicted to initiate at a non-AUG start codon (dashed line). E) 
Conservation analysis of annotated 5’UTRs in all three reading frames (far left, dark gray), 
annotated CDS regions over all three frames (middle left, blue), annotated 3’UTRs in all three 
reading frames (middle right, light gray), and predicted ORFs. Predicted ORFs are scored 
according to their termination in the 5’UTR (red), in the annotated CDS (light orange), or the 
portion of CDS-terminated ORFs that overlap the 5’UTR (dark orange).
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CHAPTER 4 
Integrative profiling of chimeric junctions with ribosome associated 
translation in prostate cancer 
 
Modified from work in progress: Chun, S.Y. and Mills, R.E. Integrative profiling of chimeric 
junctions with ribosome-associate translation in prostate cancer. 
 
The material presented in this chapter is derived from preliminary work in progress and is not 
being pursued as a manuscript at this time. Dr. Mills and I devised the context and scope of the 
analysis. Dr. Mills provided guidance for the experimental approach, and I led the development 
and implementation of the computational and analytical pipeline. 
 
 
4.1 Introduction 
 
Cancer is a significant threat to public health, and is the leading cause of death in the United States. 
In men, prostate cancer is the leading type of malignancy diagnosed, with the majority of men 
developing the disease by the age of 80. In 2017, prostate cancer is projected to be the most 
commonly diagnosed cancer type in men with over 160,000 new cases in the United States alone, 
and is predicted to be the third-leading cause of cancer related death regardless of gender.[153] As 
such, early detection and further insight into the mechanism of its development are critical to long-
term prostate cancer treatment and patient outcomes. 
 
Existing methods for early detection in the clinic are reliant on screening for prostate-specific 
antigen serum levels. However, tests for PSA may not accurately differentiate aggressive prostate 
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cancer from other milder forms, or distinguish them from benign dysplasias. Therefore, the need 
is exigent for biomarkers and methodologies that accurately and sensitively prioritize aggressive 
malignancies of the prostate.[6,154-157]  
 
The development and application of high-throughput sequencing approaches have enabled deeper 
insight into the genomic, transcriptomic and proteomic changes that underlie prostate cancer. The 
landscape of prostate cancer specific single nucleotide variants, insertions, deletions, copy number 
variants, and structural variations has emerged with the continued advancement of profiling 
methodologies and analytical algorithms.[158-162] Perhaps among the most well-characterized 
are the highly recurrent gene fusions that involve the ETS family of transcription factors, like 
TMPRSS2-ERG.[163-167] Aberrations like TMPRSS2-ERG confer a selective advantage for 
tumor cell growth and proliferation; these mutations ‘drive’ the progression of cancer. In contrast, 
the landscape of mutations in cancer are also comprised of ‘passenger’ events, which are those that 
do not provide a direct or indirect advantage to tumor cells.[168] Thus, clinicians and researchers 
recognize the need to not only identify the total catalog of aberrations in cancer, but to distinguish 
mutations that directly influence the development or progression of the disease from those that do 
not. 
 
Chimeric gene fusions offer significant diagnostic and therapeutic potential; their expression often 
dysregulates critical pathways related to cell cycle regulation, proliferation and differentiation, and 
since they are specific to malignant cells, may present opportunities for targeted therapy. 
Approximately 50% of tumor samples collected from patients positively screen for serum PSA 
harbor a TMPRSS2-ERG gene fusion.[167] As such, methods for the detection and classification 
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of known gene fusion events, as well as the identification of novel variants is under continued and 
rigorous development. [169-171] Gene fusions often drive the aberrant overexpression of the 
downstream partner. Alternatively, gene fusion events result in the creation of a protein product 
with novel or altered function from the two partners. Other gene fusions may produce a truncated 
protein with altered stability, structure, or function.[172,173] Although transcriptome sequencing 
has proven useful in the efforts to identify and characterize the contribution of chimeric gene fusion 
events to cancer, comprehensive profiling at the proteome has been elusive. Due to the lack of 
highly-specific antibodies, immuno-based detection methods are prone to high rate of false 
positive identification.[174] Furthermore, the short length and altered stability of certain gene 
fusions makes mass spectrometry-based detection less than ideal. 
 
Building on advances in next-generation library preparation and sequencing, a method was 
recently developed for the high-throughput profiling of mRNA actively bound by translating 
ribosomes.[85] Ribosome profiling is a next-generation sequence methodology designed to survey 
the landscape and dynamics of mRNA translation into protein. In tandem with mRNA-Seq, 
analysis of ribosome-protected fragments of mRNA offers significant potential to profile the 
translational efficiency of protein synthesis, and contextualize those changes against the topology 
of chimeric gene fusion events. Although transcriptional profiling has driven many insights in 
understanding the impact of gene fusion events in cancer, placing those insights within the context 
of translational dynamics may offer further clues regarding the mechanism of their expression, as 
well as their functional importance. To this end, we propose the development of an integrative 
analytical and data visualization platform for the translational profiling of junctions with ribosome-
associated translation (juncRAT). 
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In this study, we aim to establish the computational and analytical framework to survey the 
translational dynamics of chimeric gene fusions in prostate cancer; more specifically, we seek to 
characterize the translational context of these gene fusion and deconvolute the regulatory 
contribution of chimeric gene fusions to the development and progression of prostate cancer. In 
particular, we aim to spatially differentiate chimeric gene fusions by their transcriptional, and their 
translational activity. To that end, we aim to profile the translational dynamics of known, and 
newly detected gene fusion events through the integrative analysis of mRNA and ribosome 
profiling sequence data. 
 
4.3 Materials and Methods 
 
Prostate cancer cell lines and data access 
In total, we evaluated five publicly available sets of next-generation sequencing data derived from 
the prostate cancer cell line PC-3: three (3) sets of paired-end mRNA-Seq data, one (1) set of 
singled-end mRNA-Seq data, with a matched set of ribosome profiling sequence libraries (Table 
4.1). The paired-end mRNA-Seq libraries are 100 to 102 nucleotide fragments, derived from three 
separate experiments on control PC-3 cells. The single-ended mRNA-Seq library consists of 40 
nucleotide length reads from vehicle-treated PC-3 cells. The matched set of ribosome profiling 
reads is derived from the same set of vehicle-treated PC-3 cells. Biological replicate sequence 
libraries were aligned separately, and merged for subsequent analyses. Ribosome profiling and 
mRNA sequencing libraries are listed in Supplemental Table C.1. 
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Integration of known and novel gene fusion breakpoints 
Known prostate cancer specific breakpoints were downloaded from the COSMIC database (v82) 
in HGVS format.[175,176] COSMIC gene fusion records are supported by various levels of 
computational and experimental evidence through manual curation of the available research 
literature. HGVS variant records were converted to transcript coordinates, and 150 nucleotides of 
sequence upstream and downstream flanking the breakpoint were extracted from the hosted 
transcript sequence database. FASTA records for each flanked breakpoint sequence were 
generated for alignment index generation. 
 
Novel and known chimeric gene fusion breakpoints were identified using three previously 
published detection algorithms: TopHat-Fusion, STAR-FUSION, MACHETE.[169-171] TopHat-
Fusion uses a read segmentation algorithm to identify novel and known gene fusion breakpoints, 
re-maps single- or paired-end reads across those breakpoints, and then identifies candidates based 
on minimum read coverage heuristics over the breakpoint. STAR-FUSION uses a two-pass 
alignment algorithm and stringent filtering criteria to identify high confidence fusion gene 
breakpoints. MACHETE uses a two-stage approach to identify candidate gene fusions: potential 
breakpoints are identified using spanning and split read alignments, and the alignment score, 
mapping quality, and the amount of overlap of junction-spanning reads are used to build a 
statistical model and score each nominated breakpoint. 
 
For higher sensitivity and specificity of fusion breakpoint detection, only the paired-end and not 
single-ended mRNA-Seq libraries were aligned to the hg38 genome and transcriptome. Default 
parameters were specified for each detection algorithm, and all nominated breakpoints from the 
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three detection algorithms were aggregated. Specific junctions identified by a single algorithm 
were retained for subsequent re-alignment using the single-ended mRNA-Seq and ribosome 
profiling libraries. Flanking 150 nucleotide sequences upstream and downstream of the candidate 
breakpoint were extracted from hg38 transcript records and output to a FASTA file. Novel and 
known breakpoints were aggregated, and combined with annotated CDS sequences (hg38) to build 
an integrative transcriptome and breakpoint compressed query index using Bowtie (v1.1.2). 
 
Breakpoint sequence alignment and profiling by SPECtre 
For consistency in alignment parameterization, single-ended mRNA and ribosome profiling 
sequence reads were aligned to the aggregated fusion breakpoint and annotated CDS reference 
using Bowtie (v1.1.2).[62] Alignment was based on an initial seed alignment length of twenty-
four (24) nucleotides, allowing up to two (2) mismatches in the seed. Following alignment, 
breakpoints without at least one mRNA-Seq or ribosome profiling read spanning the junction were 
discarded. Putative breakpoints were further filtered based on the alignment quality of the reads 
spanning the junction, with no mismatches in the alignment permitted immediately upstream and 
downstream of the breakpoint. Thus, putatively transcribed breakpoints are defined as those 
junctions with minimum mRNA-Seq read coverage, and putatively translated breakpoints are 
defined as junctions with minimum coverage by ribosome profiling RPFs. 
 
Aligned RPFs were adjusted to their P-site offset position, and the normalized depth at each 
position in mRNA-Seq and ribosome profiling was calculated as the per-position reads per million 
mapped reads. The RPM normalized depth at each position in the breakpoint was divided by the 
maximum depth across both sequencing profiles to determine relative positional depth. The 
 78 
 
coherence of this depth-normalized RPF coverage was scored against an idealized tri-nucleotide 
signal over 30 nucleotide sliding windows across the breakpoint and flanking regions. An 
empirical model of translational potential was calculated from the distribution of SPECtre scores 
over annotated protein-coding CDS regions. In addition to the SPECtre signal profiled over each 
breakpoint and protein-coding CDS, the corresponding phase in each sliding window was 
extracted. 
 
4.4 Results 
 
Integration of known and novel chimeric gene fusion breakpoints 
Technical issues precluded the prediction of breakpoints using TopHat-Fusion and MACHETE; 
TopHat-Fusion has a known memory allocation error that prevents proper execution, and parallel 
processing of MACHETE is only possible on a cluster running Sun Grid Engine. Therefore, only 
the results of COSMIC database and STAR-FUSION prediction are presented at this time. 
 
Forty-two (42) prostate-specific HGVS gene fusion annotations were extracted from the COSMIC 
database, and converted to FASTA-formatted breakpoint sequences using a custom Python script 
(Supplemental Methods, Appendix C). Of these 42 COSMIC database breakpoints, 19 were 
identified in aggregate from STAR-FUSION prediction using the seven paired-end mRNA-Seq 
libraries (Figure 4.2A); since PC-3 is TMPRSS2-ERG gene fusion negative, it was not predicted 
by STAR-FUSION.[165] In addition to these previously annotated fusion events, STAR-FUSION 
predicted an additional 142 breakpoints that passed their default heuristic filtering criteria. These 
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previously annotated and de novo predicted breakpoints define the set of chimeric fusions to be re-
aligned by matched single-end mRNA-Seq and ribosome profiling PC-3 libraries. 
 
Breakpoint alignment using single-ended mRNA-Seq and Ribo-Seq 
As previously described, nominated breakpoints derived from COSMIC and STAR-FUSION 
detection were used to construct an integrative breakpoint database of previously annotated and de 
novo predicted junctions. Following alignment with single-ended mRNA-Seq and ribosome 
profiling libraries against this integrative junction database, 12 COSMIC gene fusions and 32 
STAR-FUSION predicted events had evidence of transcriptional or translational activity, as 
defined by minimum spanning read coverage over their junctions (Figure 4.2B). Of the 32 STAR-
FUSION nominated events, the majority were identified by only one out of the seven original 
paired-end mRNA-Seq libraries. However, several of the events are supported by a minimum of 
two, and up to six of the individual paired-end mRNA-Seq libraries (Figure 4.3). In this study, 
chimeric gene fusion breakpoints are profiled evenly by both technologies, with breakpoints 
covered by similar numbers of junction spanning reads in both mRNA-Seq and ribosome (Figure 
4.4A, p-value > 0.05). In addition, COSMIC integrated and STAR-FUSION nominated 
breakpoints are profiled to similar depths of coverage by junction spanning reads (Figure 4.4B and 
Figure 4.4C, respectively). Although only a subset of the integrated set of previously annotated 
and de novo predicted gene fusions are identified by the re-alignment of single-ended mRNA and 
RPF sequence libraries, this is not unexpected due to their shorter length (40 nt for single-ended 
mRNA and RPF libraries). Furthermore, paired-end alignments provide additional structural 
evidence for previously unannotated junctions in the absence of breakpoint spanning reads. Thus, 
alignment of single-ended mRNA-Seq and ribosome profiling reads positively identifies both 
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previously annotated and novel breakpoints generated by integrative database and de novo 
breakpoint discovery. 
 
Coherence profiling of fusion breakpoints 
In order to further define a set of highly transcribed or translated fusion breakpoints, additional 
heuristic coverage quality metrics were applied; based on a minimum junction spanning depth of 
3 mRNA-Seq or ribosome profiling fragments, and upstream and downstream read abundance, 14 
breakpoints were selected for additional spectral analysis for translational potential (Supplemental 
Table C.2). Among these 14 breakpoints, four are derived from COSMIC database integration, 
and include known ETS-family fusion events (ETV1-ACSL3, ETV1-HNRNPA2B1, and ETV4-
CANT1), and the TPM4-ALK chimeric gene fusion. Of these fourteen events, 9 are putatively 
transcribed and translated according to the mRNA-Seq and ribosome profiling spanning read 
coverage, respectively. 
 
Based on the mRNA-Seq and ribosome profiling read coverage over these junctions, several 
patterns of transcription and translation emerge, including breakpoint partners with varying levels 
of mRNA and RPF support before and after the junction (Figure 4.5), and fusion partners with 
evidence of transcriptional and translational activity both upstream and downstream of the 
breakpoint (Figure 4.6 and Figure 4.7). Transcriptional activity without corresponding 
translational evidence in the form of junction spanning RPFs may suggest alternative models of 
transcriptional or post-transcriptional regulation for other candidates (Figure 4.8). Given the 
limited sample of candidate fusions, it is still clear that in conjunction with conventional mRNA-
Seq studies, coupling them to ribosome profiling experiments may offer potential utility as 
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translational validation for chimeric transcripts, as well as present opportunities to infer alternative 
regulatory mechanisms for putative fusion partners. 
 
However, simple RPF coverage over chimeric junctions may not be sufficient to infer their active 
translation. Although the ETV1-HNRNPA2B1 junction is supported by mRNA-Seq coverage that 
spans the breakpoint, RPF coverage over the junction is nominal (Figure 4.5). Indeed, when the 
normalized RPF coverage over the breakpoint region is scored by SPECtre, a dramatic drop in tri-
nucleotide coherence is observed well before the breakpoint; this break in tri-nucleotide signal is 
suggestive that this breakpoint is not actively translated, despite the nominal spanning RPF 
coverage evidence that might indicate otherwise (Figure 4.9A). Although the coherence over the 
TXNRD1-UTP20 breakpoint decreases relative to the immediate regions upstream and 
downstream of the junction, the tri-nucleotide periodic signal is maintained across the breakpoint 
(Figure 4.9B). Although the coherence over the breakpoint itself falls relative to the proximal 
regions surrounding it, this fusion transcript may warrant further scrutiny. Likewise, coherence to 
the tri-nucleotide signal indicative of active translation is maintained across another ETV1 family 
fusion transcript (Figure 4.9C). Taken together, these results suggest alternative models of 
transcriptional and translational regulation that might be further leveraged to predict, or classify, 
the pathogenicity of gene fusion events based on their translational efficiency. 
 
4.5 Discussion 
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Initial analysis of the integrative transcriptional and translational profiling of chimeric gene fusion 
junctions in cancer are limited both in scope and depth. Despite this, preliminary results suggest 
the potential utility of further dissecting the transcriptional activity over these gene fusion 
breakpoints with added translational context. Furthermore, the computational and analytical 
foundations are in place for the high-throughput integration and interpretation of multi-scalar 
transcriptional and translational profiling of curated and de novo gene fusion predictions. Based 
on this integrative profiling, deeper insight might be gained regarding the translational efficiency 
of specific gene fusion breakpoints, and provide additional granularity for the pathogenicity of 
‘driver’ events from ‘passenger’ events.[168] 
 
Integration of copy number alterations for coverage normalization 
Initial transcriptional and translational profiling of chimeric transcripts like the ETV1-
HNRNPA2B1 fusion event invite further mechanistic scrutiny, as well as highlight areas in which 
the proposed integrative profiling approach might be improved. The coverage in both mRNA and 
RPFs is drastically higher in the 5’ partner relative to the 3’ partner. Mechanistically, the presence 
of an alternative in-frame stop codon proximal to the loss of coverage is one plausible explanation. 
However, another regulatory factor that was not accounted for in this preliminary analysis is copy 
number variation. The overexpression of many genes, including gene fusion partners, may be 
driven by underlying alterations in copy number.[177] Thus, the enrichment in mRNA and RPF 
abundance on one side of the ETV1-HNRNPA2B1 breakpoint over the other may be an artifact of 
copy number variation. One avenue to assess the underlying copy number architecture of gene 
fusion partners might be to analyze whole genome sequence data in PC-3 cells; the mRNA and 
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RPF coverage over the breakpoint could be further normalized to account for CNV differences in 
the two gene fusion partners.[178] 
 
Phase deconvolution of chimeric junction translation 
In addition to the efficiency of translation, spectral coherence profiling may also be used to predict 
the phase of the signal measured. Taking advantage of the tri-nucleotide periodicity inherent to the 
codon-dependent elongation in peptide synthesis, the phase of predicted gene fusion produces 
could be de-convoluted from the annotated canonical protein product through re-sampling analysis 
ribosome profiling reads over a chimeric junction. In this way, the translational efficiency of the 
competitively synthesized protein products (e.g. canonical versus chimeric) could be compared 
and assessed for state-dependent changes in the magnitude of translational dysregulation, such as 
solid tumors versus metastatic malignancies. 
 
Annotation of chimeric junctions with ribosome-associated translation 
To promote integrative approaches to study the genomic, transcriptional and translational factors 
that contribute to the etiology of cancer, the computational and analytical framework used for this 
pilot study could be extended and scaled for larger-scale data integration and discovery. Additional 
sources of curated and semi-curated repositories may be integrated into the database of previously 
annotated breakpoints; these resources include the Mitelman database of gene fusions 
(http://cgap.nci.nih.gov/Chromosomes/Mitelman) and other hosted repositories like 
ChimerDB.[179] As described in Section 4.3 (Methods), novel fusion breakpoints identified by 
additional detection algorithms like MACHETE and TopHat-Fusion are planned for integration. 
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Since ribosome profiling serves as a level of translational validation, one advantage of the 
proposed pipeline is that rare, lowly expressed variants, or other fusion transcripts that are 
discarded by the heuristic filters of certain fusion discovery algorithms may be included for 
ribosome profiling analysis. For instance, one of the heuristic filters employed by the STAR-
FUSION pipeline filters out promiscuous fusion partners; fusion transcripts that include 
promiscuous 5’ or 3’ partners may be retained for full translational investigation. To this end, we 
propose the creation of a data warehouse and visualization platform for the integrative analysis 
and annotation of chimeric junctions with ribosome-associated translation, or juncRAT. 
 
Adaptation of randomized approaches to define breakpoints in the genome and transcriptome 
Relatively few studies have evaluated the impact of genomic structural variants that result in the 
translocation of constitutively or aberrantly active promoter regions proximal to genes relevant to 
cancer development and progression. Furthermore, many of the current discovery platforms for 
fusion detection rely on conservative heuristic algorithms to filter out candidate breakpoints. For 
example, TopHat-Fusion and other callers like STAR-FUSION employ minimum junction overlap 
by spanning reads to identify a high confidence set of fusion transcripts.[169,171] In some 
respects, these minimum overlap cutoffs may be considered arbitrarily conservative and enrich for 
artifacts of amplification.[170] Randomized approaches to identify breakpoints using short read 
sequencing technology have been shown to sensitively and accurately identify SVs in the 
genome.[180] To fully capture the landscape of genomic and transcriptomic structural variants we 
propose to apply and adapt existing software to call pathogenic breakpoints from whole genome 
sequencing data, and identify previously annotated and novel chimeric junctions from paired-end 
transcriptomic data, respectively. Integration and translational validation of breakpoints identified 
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from this method established for calling genomic structural variants offers additional opportunities 
for collaborative and comparative research in the investigation of pathogenic gene fusion events 
in cancer. 
 
4.6 Conclusion 
 
The work detailed in this chapter of the dissertation lays the computational and analytical 
framework for the integrative profiling of the transcriptional and translational landscape of 
chimeric gene fusion transcripts in prostate cancer. Analysis of ribosome profiling coverage and 
translational activity over chimeric gene fusion breakpoints provides further evidence for their 
potential pathogenic contribution to cancer. In this way, the translational context provided by 
ribosome profiling may enable the increasingly granular characterization of the genomic and 
transcriptomic events that drive cancer development and its progression. 
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Figure 4.1 Schematic of the juncRAT alignment and analytical pipeline. 
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Figure 4.2 Integrative chimeric gene fusion breakpoint alignment. A) Number of novel fusion 
events (left), and the number of previously annotated fusion events identified by STAR-FUSION 
(middle). COSMIC events are the total number of prostate cancer specific events curated in the 
annotation database (v82). B) The number of COSMIC and novel events identified by re-alignment 
over those breakpoints with single-ended mRNA-Seq and ribosome profiling reads. 
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Figure 4.3 Paired-end library support of STAR-FUSION events. The number of events supported 
by at least one paired-end mRNA-Seq library, and those supported by multiple mRNA-Seq 
libraries. 
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Figure 4.4 Number of spanning reads by breakpoint source and profiling method. A) Cumulative 
distribution of junction spanning reads profiled by mRNA (red), and RPF (blue). B) Cumulative 
distribution of junction spanning reads over COSMIC integrated breakpoints (red), and novel 
breakpoints (blue) identified by mRNA-Seq alignment by STAR-FUSION. C) Cumulative 
distribution of junction spanning RPFs over COSMIC integrated breakpoints (red) and novel 
STAR-FUSION breakpoints (blue).  
 90 
 
 
 
Figure 4.5 Coverage over the ETV-HNRNPA2B1 breakpoint junction. Normalized read coverage 
profile derived from mRNA-Seq (top, red) and ribosome profiling (bottom, blue). Read coverage 
is normalized by library size and then divided by the maximum depth in mRNA-Seq or Ribo-Seq 
to generate relative abundance over each position. 
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Figure 4.6 Coverage over the TXRND1-UTP20 breakpoint junction. Normalized read coverage 
profile derived from mRNA-Seq (top, red) and ribosome profiling (bottom, blue). Read coverage 
is normalized by library size and then divided by the maximum depth in mRNA-Seq or Ribo-Seq 
to generate relative abundance over each position. 
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Figure 4.7 Coverage over the ETV1-ACSL3 breakpoint junction. Normalized read coverage 
profile derived from mRNA-Seq (top, red) and ribosome profiling (bottom, blue). Read coverage 
is normalized by library size and then divided by the maximum depth in mRNA-Seq or Ribo-Seq 
to generate relative abundance over each position. 
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Figure 4.8 Coverage over the CCT7-DYNC1H1 breakpoint junction. Normalized read coverage 
profile derived from mRNA-Seq (top, red) and ribosome profiling (bottom, blue). Read coverage 
is normalized by library size and then divided by the maximum depth in mRNA-Seq or Ribo-Seq 
to generate relative abundance over each position. 
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Figure 4.9 Ribosome profiling validation of junction translation. A) Spectral coherence profile 
over the COSMIC breakpoint ETV-HNRNPA2B1. Spectral coherence measures the strength of 
the tri-nucleotide periodicity inherent to active translation. B) Coherence profile over the STAR-
FUSION chimeric junction candidate TNXRD1-UTP20 demonstrates decreased, but continuous, 
tri-nucleotide periodic signal across and through the nominated breakpoint. C) Continuous tri-
nucleotide periodicity is observed across the COSMIC breakpoint ETV4-ACSL3 indicative of 
translational potential through the junction.  
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CHAPTER 5 
Concluding Remarks and Future Directions 
 
5.1 Translational Profiling and Protein Synthesis 
 
Estimates of mRNA abundance have often been used as a proxy for protein synthesis, however 
direct comparison if complicated by both biological and technical considerations; multiple 
regulatory mechanisms may alter the abundance, structure, or localization of an mRNA or protein, 
and comprehensive characterization of the mRNA or proteomic content of a cell remains elusive 
due to technological or algorithmic limitations of the survey methodology employed. For instance, 
the short length and half-life of many uORFs may make their detection by mass spectrometry at 
the proteomic level difficult. Further, previous studies have demonstrated that direct comparison 
of mRNA and protein abundance, although positively correlated, are only moderately so. Since 
ribosome profiling involves the sequencing and analysis of mRNA directly engaged by actively 
translating ribosomes, it is strategically positioned to more intimately monitor the dynamics of 
protein synthesis than transcriptome sequencing. Indeed, early ribosome profiling experiments 
demonstrated that the abundance of ribosome-protected fragments of mRNA was more highly 
correlated with mass spectrometry estimates of protein abundance. However, given its relatively 
recent development, and specific limitations regarding library preparation and analysis, further 
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work may be required to more fully entrench ribosome profiling as a standard component of 
integrative transcriptional and translational studies.  
 
Although protein synthesis estimates derived from the abundance of ribosome-protected fragments 
of mRNA are more highly correlated with mass spectrometry readouts of protein expression, 
technical limitations of the ribosome profiling methodology persist that prevent it from supplanting 
mRNA-Seq. In particular, ribosome profiling experiments are contaminated by higher levels of 
ribosomal RNA than comparable mRNA-Seq experiments; in practice, this means that typical 
ribosome profiling experiments capture less of the transcriptome at lower average depth of 
coverage. This reduced depth and diversity of transcriptome coverage by ribosome profiling 
relative to mRNA-Seq may be partially mitigated through a combination of additional sequencing 
investment and experimental design. In spite of this reduced depth and diversity of transcriptome 
coverage relative to mRNA-Seq, ribosome profiling estimates of protein synthesis are more highly 
aligned with protein expression. Furthermore, as a bridge between the transcriptome and proteome, 
ribosome profiling enables increasing insight into the mechanism of translation and translational 
regulation.  
 
For instance, various ribosome profiling studies have been published that demonstrate engagement 
of the translational machinery outside of canonically annotate protein-coding regions, including 
uORFs. Since these uORFs are typically short in length and half-life, they are generally difficult 
to detect by mass spectrometry without size selection or N-terminal enrichment. Although uORFs 
had been shown previously to be important regulators of protein synthesis in limited contexts, 
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ribosome profiling is helping to further define their prevalence and contribution to the regulatory 
landscape of cellular control and diversity. In addition to the engagement of ribosomes over 
uORFs, several experiments have observed ribosomes engaged over long non-coding RNA loci 
with conflicting proteomic evidence. Although one group detected ribosomes engaged on long 
non-coding RNA regions, they were unable to find evidence of their translation by mass 
spectrometry, and concluded that their engagement by ribosomes was not indicative over active 
translation. Later, other groups detected a subset of long non-coding RNAs by mass spectrometry, 
and further defined their translational status by shared characteristics of ribosome-protected 
fragment coverage with protein-coding loci. Taken together, these results underscore the utility of 
ribosome profiling as an intermediate methodology to study translation and protein synthesis, as 
well as the need for the continued development and application of algorithms described in this 
thesis to more comprehensively characterize both the mechanism of translation and the global 
cellular impact of translational regulation. 
 
5.2 Spectral Coherence Profiling 
 
In chapter 2 of this dissertation, I presented SPECtre: an algorithm and software package to reliably 
identify regions under active translation in ribosome profiling sequence data using an approach 
that leverages the tri-nucleotide periodicity of codon-dependent peptide elongation. Spectral 
coherence is a signal processing algorithm originally developed for pattern recognition in time 
series data, and measures the similarity of two signals over the frequency domain. Although 
foundational aspects of this profiling methodology were preceded by another group using a similar 
 98 
 
approach, this underscores the utility and potential advantages of translational profiling using a 
coherence-based approach. However, the translational coherence classification algorithm and 
software package presented in this differs from the earlier established method in two key aspects: 
codebase optimization resulted in more efficient usage of computational resources, but more 
significantly, SPECtre achieves comparable sensitivity and specificity in translational 
classification in the absence of matched mRNA-Seq data. Although deeper insight is gained by 
the tandem, and integrative analysis of transcriptional and ribosome profiling data, obviation of 
matched mRNA-Seq samples for translational analysis grants researchers wider latitude in 
experimental design. 
 
5.3 Computational Prediction of Regulatory uORFs 
 
In the third chapter of this dissertation, we extended the spectral coherence approach for 
classification of active translation to identify upstream-initiated open-reading frames with context-
specific regulatory potential. A subset of computationally predicted uORFs that negatively 
regulate their corresponding protein-coding gene were experimentally validation in differentiated 
SY-SY5Y cells. Furthermore, we investigate multiple factors that might contribute to the 
regulatory impact of these ORFs. In addition to the translational activity of the uORF, sequence 
conservation and content, as well as spatial proximity to the annotated protein-coding region are 
predictive of its potential regulatory impact on protein synthesis. Importantly, we found that many 
of these translationally repressed genes are related to cell cycle control, regulation of cell division, 
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and chromosome organization. Finally, a limited subset of these uORFs was experimentally 
validated to negatively regulate protein synthesis in a cellular model of neuronal differentiation. 
 
With the advent of translational profiling approaches like the next-generation sequencing of 
ribosome-protected fragments of mRNA, efforts to more comprehensively map the intricate 
network of protein synthesis regulation have intensified. Methods for the analysis of translational 
efficiency and dynamics using ribosome profiling data are under continued, and rigorous, 
development. Like SPECtre, some approaches have leveraged the tri-nucleotide periodic signal 
inherent to the codon-dependent mechanism of peptide elongation; however, I note several areas 
in which translational classification algorithms, including SPECtre, could be extended to more 
sensitively and specifically identify regions under active translation and explore their context-
specific regulation implications. The work presented in this chapter of the dissertation underscores 
the contribution of multiple sequence and spatial parameters that underlie the regulatory potential 
of uORFs. However, additional parameters that were not assessed include mRNA secondary 
structure, k-mer content, tRNA abundance, and codon usage bias. Previous studies have 
demonstrated the significance of mRNA secondary structure on non-AUG translation initiation in 
certain contexts. Furthermore, tRNA abundance and codon usage bias have been shown to 
moderate the translational efficiency of transcripts in a resource-dependent manner. Finally, 
uORFs were predicted in a supervised manner; given the number of factors included (and not 
included) in our multiple regression model, the robust feature selection of unsupervised machine 
learning approaches may be well-suited for the sensitive and accurate prediction of translated 
uORFs with regulatory potential. 
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5.4 Translational Profiling of Chimeric Junctions 
 
In chapter 4 of this dissertation, I proposed a framework for the integrative profiling of the 
transcriptional and translational landscape of gene fusions in cancer. High-throughput, massively 
parallel next-generation sequencing has empowered deeper insight into the genomic and 
transcriptional regulatory landscape that underlies the development of cancer and its progression. 
Immunoassay-based approaches to detect chimeric gene fusion events in tumor samples are limited 
by the availability and specificity of high-quality antibodies. High-throughput mass spectrometry 
and database search methods have become increasingly sensitive in their detection of gene fusion 
events, but some of these chimeric events may be difficult to capture due to their altered size, 
structure, or localization. Moreover, some gene fusion events may not be detected in the proteome 
due post-transcriptional regulation or decreased stability.  
 
This work lays the initial computational and analytical framework for the integrative investigation 
of the transcriptional and translational landscape of chimeric gene fusion events in a context-
specific manner across cancer. Based on preliminary alignment and analysis of mRNA-Seq and 
ribosome profiling reads, we observed differential patterns of transcriptional and translational 
coverage over a limited set of previously annotated and novel chimeric breakpoint junctions. 
Aspects in which this preliminary work could be immediately extended include the aggregation of 
additional curated databases of chimeric gene fusions, and the integration of multiple gene fusion 
calling pipelines to more comprehensively catalog potentially pathogenic chimeric events in 
cancer. Moreover, increasingly robust analysis of the transcriptional and translational coverage 
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over these chimeric junctions would account for copy number variations across the two fusion 
partners. However, these preliminary findings suggest the importance of accounting for 
translational regulation in the pathogenic characterization of gene fusion events, as well as for their 
suitability as potential biomarkers or therapeutic targeting. Tandem and integrative analysis of 
mRNA-Seq and ribosome profiling data could be readily adapted to existing clinical sequencing 
protocols, and offer deeper insight into the context-specific changes in the transcriptional and 
translational landscape that underlies cancer.  
 
5.5 Concluding Note on Translational Profiling 
 
As a relatively recent entrant into the field of next-generation sequencing, ribosome profiling and 
corresponding methods for its analysis are under continued and rigorous development. Through 
these efforts, we have gained deeper understanding of the diverse network of translational 
regulation that underlies gene expression and protein synthesis. However, early efforts were 
focused, and continue to be focused on assessing the prevalence and significance of uORF 
translation. Although continued development of analytical and computational algorithms is needed 
to meet these challenges, it seems to me that these advancements and the product of these efforts 
must be appropriately contextualized against the background of dynamic cell states and conditions. 
The field, including the work presented in this dissertation, has begun to shift from identifying the 
global prevalence of uORF translation to dissecting their role across cellular states. Likewise, the 
compendium of genomic and transcriptomic aberrations in cancer continues to grow as larger 
cohorts of tumor samples are sequenced and analyzed. The continued development of rigorous 
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analytical algorithms, and the growing computational resources to drive their application is leading 
the way for personalized medicine, including targeted cancer therapeutics. These therapeutic 
targets or diagnostic markers may be more efficiently identified if the underlying mechanism of 
their transcriptional and translational regulation is more fully understood. The work of integrating 
and analyzing this data will present exciting challenges, and empower deeper understanding of the 
dynamic changes that define cellular states. 
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APPENDIX A 
SUPPLEMENTAL MATERIAL FOR CHAPTER 2 
 
A.1 Supplemental Methods 
 
Data access and pre-processing 
HEK293 ribosome profiling alignments in BAM format, were downloaded from the data 
repository hosted by the authors of RiboTaper (https://ohlerlab.mdc-
berlin.de/files/RiboTaper/alignment_files.tar.gz).[100] No further pre-processing for the HEK293 
alignments was required. Zebrafish ribosome profiling libraries) were downloaded from the NCBI 
Gene Expression Omnibus (accession GSE53693).[99] Ribosome profiling data of mouse 
embryonic stem cells treated with cycloheximide was downloaded from GEO (accession 
GSE60095, sample GSM1464901).[95]  
 
Mouse embryonic stem cell and zebrafish ribosome profiling sequence libraries were converted 
from SRA format to FASTQ. mESC ribosome profiling reads were trimmed of adapters according 
to previously published methods.[95] Adapter sequences were removed from zebrafish ribosome 
profiling reads and further trimmed based on base quality using fastq-mcf 
(https://github.com/ExpressionAnalysis/ea-utils). For both trimming methods, a minimum read 
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length of 24 nucleotides was required after adapter removal and supplemental trimming. The 
minimum threshold for base quality trimming using fastq-mcf was set to 10 over a consecutive 
window of 4 nucleotides. All sequence libraries were then aligned to their respective UCSC 
ribosomal RNA contaminant database; mm10 for mESC, and Zv9 for zebrafish embryos.[181] 
Sequence reads were aligned to their respective ribosomal RNA contaminant database using 
Bowtie version 1.1.2 with a seed length of 22 nucleotides, and allowing no mismatches in the seed 
alignment.[62]  
 
Alignment and post-alignment processing 
Mouse and zebrafish ribosome profiling reads that did not map to their respective ribosomal RNA 
contaminant database were aligned using TopHat version 2.0.[182] Zebrafish ribosome profiling 
reads were aligned to the Ensembl v78 genome and transcriptome references.[183] Mouse 
embryonic stem cell ribosome profiling sequence reads were aligned to the Ensembl v72 genome 
and transcriptome reference. All ribosome profiling sequence reads were aligned with TopHat 
parameters that required Bowtie v1.0.0, Solexa quality scores, no novel junctions to be generated, 
with a forward/unstranded library type designated. 
 
Aligned mESC and zebrafish reads were filtered based on a minimum mapping quality of 10 using 
SAMTools, and then sorted by genomic position using Picard version 1.114 
(http://broadinstitute.github.io/picard).[184] For meta-analysis of the zebrafish ribosome profiling 
data, aligned reads from the sixteen available zebrafish samples and replicates were merged into a 
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single BAM alignment file using Picard. Shell scripts and code specific to each experiment are 
reproduced in the proceeding sections. 
 
A.2 SPECtre 
Read coverage normalization 
For a given transcript with coordinates defined by the set C, the A- or P-site adjusted read positions 
overlapping those coordinates are extracted from a BAM alignment file. The coverage over each 
coordinate position in the set is summed, then normalized to the highest coverage such that all 
coordinate positions defined by set C range from zero (no coverage) to one (highest coverage).  
 
Spectral coherence 
In signal processing, coherence measures the power relationship between two signals as a function 
of frequency. Coherence estimates range from zero, where two signals are fully independent of 
each other, to one, where one signal may be perfectly predicted by the other.  Assuming a sampling 
interval Δ over time interval T, signal Xj and its Fast Fourier Transform (FFT) Xj* define the power 
spectrum of signal X at frequency j as: 
(1) 
𝑆𝑋𝑋,𝑗 =  (
2∆2
𝑇
) 𝑋𝑗𝑋𝑗
∗ 
The cross-power spectrum of signal Xj and Yj at frequency j, is calculated as the mean of the 
product of signal Xj and the Fast Fourier Transform of signal j over K trials: 
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(2) 
< 𝑆𝑋𝑌,𝑗 > =  (
2∆2
𝑇
) (
1
𝐾
) ∑ 𝑋𝑗,𝑘
𝐾
𝑘=1
𝑌𝑗,𝑘
∗  
Coherence is defined as the magnitude of the cross-power spectrum between signal X and Y at 
frequency j divided by the product of the square roots of the power spectrum of signal X at 
frequency j, and the power spectrum of signal Y at frequency j. 
(3) 
𝐶𝑜ℎ𝑋𝑌,𝑗 =  
|< 𝑆𝑋𝑌,𝑗 >|
√< 𝑆𝑋𝑋,𝑗 > √< 𝑆𝑌𝑌,𝑗 >
 
 
SPECtre scoring 
The default SPECtre score is calculated as the average coherence over N nucleotide sliding 
windows across a normalized coverage region against an idealized tri-nucleotide control signal of 
the same length.[104] Welch’s coherence decreases the variance of the coherence estimate at the 
expense of resolution. Alternatively, modified Welch’s coherence estimates over a region may be 
calculated using the median, maximum, or the non-zero mean or median. The SPECtre score of a 
normalized coverage region R with coordinates C, at frequency j against an idealized tri-nucleotide 
signal S, over adjacent N nucleotide windows is given by: 
(4) 
𝑆𝑝𝑒𝑐𝑅𝑆,𝑗 =  
1
𝑀
∑ 𝐶𝑜ℎ𝑅𝑚,𝑚+𝑁𝑆𝑁,𝑗
𝑀
𝑚=1
 𝑓𝑜𝑟 𝑎𝑙𝑙 𝑚 + 𝑁 ∈ 𝐶 
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The number of sliding windows over the coordinate set C may be modified based on the step size 
between each window. Given a coordinate set C, and step size of L: 
(5) 
𝑊𝑛 = 𝐶𝐿𝑛, 𝑓𝑜𝑟 𝑛 ≥ 1 𝑎𝑛𝑑 𝐿 ≥ 1  
Therefore, the default SPECtre score of a normalized coverage region R, at frequency j against an 
idealized tri-nucleotide signal S, over N nucleotide windows with a step size of L is: 
(6) 
𝑆𝑝𝑒𝑐𝑅𝑆,𝑗 =  
1
𝑀
∑ 𝐶𝑜ℎ𝑅𝑚,𝑚+𝑁𝑆𝑁,𝑗
𝑀
𝑚=1
 𝑓𝑜𝑟 𝑎𝑙𝑙 𝑚 ∈ 𝑊𝑛 𝑎𝑛𝑑 𝑎𝑙𝑙 𝑚 + 𝑁 ∈ 𝐶 
 
A.3 Analysis of Read Length Bias 
Treatment with cycloheximide typically isolates ribosome-protected fragments 28 to 30 
nucleotides in length, which align with high fidelity to regions annotated to protein-coding 
transcripts.[85] However, in the absence of cycloheximide, conformational changes in the 
ribosomal complex may enrich for a shorter range of RPFs that also map with high-fidelity to 
regions annotated to protein-coding transcripts.[92] It is possible that these shorter length RPFs 
may obscure the tri-nucleotide signal of longer length RPFs that may cause coherence-based 
classifiers, like SPECtre, to under-estimate the number of actively translated ORFs in a ribosome 
profiling experiment. Ideally, this could be tested using simulated data as is done for whole genome 
sequencing using wgsim (https://github.com/lh3/wgsim) or RNA-Seq.[185] However, unlike 
RNA-Seq, simulation of RPFs would have to account for the distribution of RPFs protected by 
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ribosomes (Figure A.1, see “All Reads”) as well as variance in the tri-nucleotide periodicity signal 
once those RPFs are aligned to the transcriptome. Instead of simulating an entire ribosome 
profiling experiment, we have examined the robustness of SPECtre scoring as a function of 
increased variance in RPF lengths outside of the expected 28-30 nt range. We have simulated this 
by randomly sampling 10,000 RPFs from the over 500,000 mESC RPFs aligned to the 
housekeeping gene ACTB using a weighted biased probability function. 
 
Given a distribution of aligned RPF lengths, D, in a ribosome profiling experiment, with the RPF 
lengths defined by the set, L = {18, 19, 20, …, 38, 39, 40}, and the relative frequency of each RPF 
length given by pLn, we define the weighted bias for a given RPF length to be randomly sampled 
as: 
(7) 
𝑊𝐿𝑛 =  
𝑝𝐿𝑛
𝑝𝐿𝑛
𝑏  
Where b is the bias assigned to the sampling distribution, such that if b = 1 the weighted bias for 
a given RPF length to be randomly sampled would be defined by the experimental RPF length 
frequencies. In contrast, if b = 2, the weighted bias for a given RPF length to be randomly sampled 
would be defined by the inverse of the experimental RPF length frequencies. The effect of 
increasing b from 1.0 to 2.0 may be seen in Supplemental Figure 1; starting with b = 1, the random 
sampling (with replacement) of 10,000 reads from the ~500,000 RPFs aligned to ACTB closely 
conforms to the experimental RPF length distribution (Supplemental Figure 1, see “All Reads”). 
As b is increased from 1.0 to 2.0, the RPF length distribution demonstrates increased variance in 
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RPF lengths outside of the expected enrichment of 28-30 nt fragments to the extent that the RPF 
length distribution progressively resembles a uniform distribution. 
 
Incrementing b from 1.0 to 2.0, we sampled 10,000 RPFs from ~500,000 aligned to ACTB with 
replacement using the sample() function in R. Sampling was performed with replacement due to 
the low number of RPFs at the low and high extremes, and to simulate the persistence of sequence 
duplication. This biased re-sampling was done over 10,000 trials, and in each trial the normalized 
read coverage over ACTB was calculated then scored using SPECtre against an idealized tri-
nucleotide periodic signal of the same length. The results of these biased sampling simulations are 
shown in Supplemental Figure A.2; as b is increased from 1.0 to 2.0, the distribution of SPECtre 
scores is plotted with the median score denoted by the dark black inside each box, and the 
extremities depicted by the ends of each whisker. The horizontal black line represents the mean 
SPECtre score over all simulations; the dashed lines above and below mark the boundaries of the 
extreme outlier cutoff as defined by Tukey. Tukey’s outlier cutoffs are defined as 1.5 times the 
inter-quartile range. Base on this outlier analysis of 10,000 trials over an increasing weighted bias 
for RPF length selection, SPECtre is robust against increasing variance in RPF lengths outside of 
the expected (28-30 nt) range. 
 
A.4 Experimental Scripts 
Adapter removal in read quality trimming 
# For mESC libraries: 
fastx_clipper -Q33 -a CTGTAGGCACCATCAAT -l 24 -c -n –v –i /path/to/FASTQ > clipped.fq 
fastx_trimmer -Q33 -f 2 -m 24 -i /path/to/clipped.fq > trimmed.fq 
 
# For zebrafish ribosome profiling library: 
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fastq-mcf -o /path/to/trimmed.fq -l 24 -q 10 -w 4 -t 0 /path/to/adapter.fa /path/to/FASTQ 
 
Alignment to rRNA contaminant database 
Ribosomal rRNA sequences may be downloaded as part of the iGenomes annotation 
(https://support.illumina.com/sequencing/sequencing_software/igenome.html) package, or from 
the UC-Santa Cruz Table Browser (https://genome.ucsc.edu/cgi-bin/hgTables). 
bowtie -l 22 -n 0 -S --un ribo-rRNA.fq /path/to/rRNA_index /path/to/trimmed.fq > rRNA.sam 
 
Alignment to reference transcriptome and genome 
tophat --bowtie1 \ 
--solexa-quals \ 
--no-novel-juncs \ 
--library-type fr-unstranded \ 
--GTF /path/to/GTF \ 
–o /path/to/alignments \ 
/path/to/genome_index \ 
/path/to/ribo-rRNA.fq 
 
Alignment post-processing 
samtools view –b –q 10 /path/to/alignments/accepted_hits.bam > filtered_hits.bam 
 
samtools index filtered_hits.bam 
 
 
A.5 Example Analysis 
 
Test data 
The test data available on the SPECtre GitHub repository consists of human SH-SY5Y 
neuroblastoma ribosome profiling (treated with cycloheximide) sequence alignments limited to 
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the Ensembl v78 human chromosome 3 genome and transcriptome references. Likewise, the 
annotation database is limited to human chromosome 3 for testing purposes. 
 
Test analysis 
python /path/to/SPECTre.py \ 
--input /path/to/test.bam \ 
--output /path/to/spectre_test.txt \ 
--log /path/to/spectre_test.log \ 
--gtf /path/to/Homo_sapiens.GRCh38.78.test.gtf \ 
--fpkm /path/to/isoforms.fpkm_tracking \ 
--len 30 \ 
--fdr 0.05 \ 
--min 3.0 \ 
--type mean \ 
--floss \ 
--orfscore 
 
Cluster script 
For faster runtime, SPECtre may be parallelized and submitted to a compute cluster. A sample 
PBS script is provided below: 
#!/bin/bash 
 
#PBS -N spectre_test 
#PBS -l nodes=8,mem=32gb,walltime=96:00:00 
#PBS -m abe 
#PBS -M stonyc\@umich.edu 
#PBS -d . 
#PBS -V 
 
#PBS -o spectre_test.out 
#PBS -e spectre_test.err 
 
python /path/to/SPECTre.py \ 
--input /path/to/test.bam \ 
--output /path/to/spectre_test.txt \ 
--log /path/to/spectre_test.log \ 
--gtf /path/to/Homo_sapiens.GRCh38.78.test.gtf \ 
--fpkm /path/to/isoforms.fpkm_tracking \ 
--nt 8 \ # use up to 8 processors 
--len 30 \ 
--fdr 0.05 \ 
--min 3.0 \ 
--type mean \ 
--floss \ 
--orfscore 
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Weighted bias sampling 
For increasing bias, b, RPFs aligned to ACTB are sampled, converted into a normalized coverage 
vector, and then scored using SPECtre. The R script for a single bias is shown below, which can 
be run in parallel with other biases for faster runtime and efficiency: 
# LOAD READS INTO R: 
reads <- read.delim("/dir/to/ACTB_reads.txt", stringsAsFactors=FALSE) 
 
read_coverage <- function(positions.vector) { 
 coverage <- rep(0, times=1128) 
 coverage.table <- table(positions.vector) 
 positions = as.numeric(names(coverage.table)) 
 depth = as.vector(coverage.table) 
 for (i in 1:length(positions)) { 
  coverage[positions[i]] <- depth[i] 
 } 
 return(coverage) 
} 
 
normalized_coverage <- function(cov) { 
 return(cov/max(cov)) 
} 
 
roundup <- function(x, to=3) { 
 to*(x%/%to + as.logical(x%%to)) 
 } 
 
calculate_spectre_score <- function(normalized.coverage, window.size, step.size) { 
 coherences <- numeric() 
coding.coverage <- rep(c(4/6,1/6,1/6), 
times=roundup(length(normalized.coverage)/3))[1:length(normalized.coverage)] 
 for (i in seq(1, length(normalized.coverage)-30, 3)) { 
  j = i + window.size 
  if (sum(normalized.coverage[i:j]) == 0 || is.na(sum(normalized.coverage[i:j]))) { 
   coherences <- c(coherences, 0.0)   
  } else { 
test.spec <- spec.pgram(data.frame(normalized.coverage[i:j],  
coding.coverage[i:j]), spans=c(3,3), plot=FALSE) 
   coherences <- c(coherences, test.spec$coh[which(abs(test.spec$freq-1/3) ==  
min(abs(test.spec$freq-1/3)))]) 
  } 
 } 
 return(mean(coherences)) 
} 
 
sample_reads <- function(df, sample.size, weight) { 
 reads <- data.frame(name=rep(NA, times=sample.size), len=rep(NA, times=sample.size), pos=rep(NA, 
times=sample.size)) 
 names <- sample(df$read, size=sample.size, replace=TRUE, prob=df$p/(df$p^weight)) 
 for (i in 1:length(names)) { 
  read.name <- unlist(strsplit(names[i], split="\\|"))[1] 
  read.len <- as.numeric(unlist(strsplit(names[i], split="\\|"))[2]) 
  read.pos <- as.numeric(unlist(strsplit(names[i], split="\\|"))[3]) 
  reads[i,"name"] <- read.name 
  reads[i,"len"] <- read.len 
  reads[i,"pos"] <- read.pos 
 } 
 return(reads) 
} 
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reads.dist <- data.frame(c(18:40)) 
colnames(reads.dist) <- c("len") 
# CALCULATE DISTRIBUTION OF READ LENGTHS: 
reads.dist$num <- NA 
reads.dist$ratio <- NA 
for (i in 1:length(reads.dist[,1])) { 
 reads.dist[i,"num"] <- length(reads$len[reads$len==reads.dist[i,"len"]]) 
 reads.dist[i,"ratio"] <- length(reads$len[reads$len==reads.dist[i,"len"]])/length(reads$len) 
} 
 
# INITIALIZE THE SCORING MATRIX: 
scores <- numeric() 
weight <- 1.0 
 
# CALCULATE SPECTRE SCORE FOR VARIABLY BIASED SAMPLING OF READ LENGTHS OVER ACTB: 
n.trials = 10000 # Number of trials. 
n.sample = 10000 # Sample size. 
for (i in 1:n.trials) { 
 sampled.reads <- sample_reads(reads, n.sample, weight) 
 sampled.coverage <- read_coverage(sampled.reads$pos) 
 sampled.coverage.nlz <- normalized_coverage(sampled.coverage) 
 sampled.spec <- calculate_spectre_score(sampled.coverage.nlz, 30, 3) 
 scores[i] <- sampled.spec 
 print(paste(Sys.time(), paste(weight, i, sep=": "), sep=" ")) 
} 
 
A.6 Data Access 
 
mESC, GSE53693[95] 
Zebrafish, GSE60095, sample GSM1464901[99] 
HEK293, https://ohlerlab.mdc-berlin.de/files/RiboTaper/alignment_files.tar.gz[100] 
 
A.7 Usage and Implementation 
 
Usage 
The files required for SPECtre analysis are an indexed alignment file in BAM format, an isoform-
level expression tracking file output from Cufflinks, and a transcript annotation file in the form of 
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a Gene Transfer Format (GTF, version 2.2+) file.[58] GTF annotation files may be downloaded 
from the UCSC Genome Browser or the Ensembl archive. User-defined arguments to specify the 
SPECtre scoring method (mean, median, maximum, etc.), the length of the windows over which 
to calculate the spectral coherence, minimum FPKM cutoffs, and FDR thresholds to calculate the 
Bayesian posterior probability of translation for each transcript are provided. Implementations of 
the FLOSS metric and ORFscore have also been made available as optional command-line 
arguments. Finally, an option to calculate the un-windowed spectral coherence of the full length 
of a transcript has been provided. 
 
Output 
Depending on the detail requested, the end-user will be provided with a tab-delimited text 
document with annotation information relevant to each transcript tested, including a unique 
identifier, genomic coordinates of the CDS and UTR regions, transcript abundance, the normalized 
read coverage over each region, the user-defined spectral coherence metric, and the Bayesian 
posterior probability of each transcript to be classified as actively translated. Optionally, the 
respective fragment length distribution and FLOSS metric, and the total number of reads over each 
frame and ORFscore may be calculated and output for each transcript. The spectral coherence 
score distribution for translated versus non-translated transcripts, and summary ROC and AUC 
plots are generated for user review. All plots generated by the SPECtre analytical package are 
output in PDF format. 
 
Implementation 
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SPECtre is a standalone analytical package written in Python, and is intended to run on a wide 
range of platforms. Therefore, installation of only a limited number of non-standard modules is 
required. SPECtre requires the following non-standard modules: NumPy and RPy2 
(http://rpy.sourceforge.net), and HTSeq.[186,187] HTSeq is used to convert alignments from the 
BAM or SAM input into transcript coverage, hash transcript intervals, and check for overlaps. 
Prior installation of R and the ROCR package are required to perform the ROC analyses and 
generate summary plots.[188] Shell scripts and SPECtre analysis for typical single sample and 
multi-sample comparative analyses are available as Supplementary Material and via the SPECtre 
GitHub repository. 
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Table A.1. Number of reads remaining at each stage of pre-processing, alignment and quality 
filtering of ribosome profiling libraries derived from mESC and zebrafish. The percentages listed 
are relative to the previous number of reads. 
  
Number Percent Number Percent Processing Step
310,854,993 n/a 1,902,337,857 n/a Raw
268,719,953 86.4 1,746,870,724 91.8 After adapter removal and trimming
128,734,835 47.9 1,276,335,857 73.1 After alignment to rRNA database
122,290,796 95.0 1,113,387,047 88.8 After alignment to transcriptome + genome
94,225,088 77.1 591,916,525 52.2 After MAPQ filtering
Ingolia (2014) Bazzini (2014)
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Table A.2. Translational classification accuracy in mESC and zebrafish. AUC for each 
classification algorithm at various minimum FPKM cutoffs for ribosome profiling derived from 
zebrafish, and mESC. In addition to the default length of 30 nt sliding windows, 60 nt and 90 nt 
windows were also tested. 
  
Method 0.5 1.0 3.0 5.0 10.0
FLOSS 0.779 0.773 0.759 0.755 0.747
ORFScore 0.584 0.591 0.606 0.619 0.634
SPECtre (30nt) 0.877 0.876 0.881 0.888 0.897
SPECtre (60nt) 0.852 0.850 0.859 0.867 0.870
SPECtre (90nt) 0.837 0.838 0.848 0.853 0.849
FLOSS 0.941 0.925 0.889 0.864 0.837
ORFScore 0.573 0.580 0.582 0.589 0.594
SPECtre (30nt) 0.955 0.936 0.900 0.885 0.872
SPECtre (60nt) 0.938 0.911 0.874 0.860 0.844
SPECtre (90nt) 0.913 0.889 0.859 0.844 0.825
B
az
zi
n
i
In
g
o
li
a
FPKM Cutoff
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Figure A.1. Read length distribution of RPFs aligned to ACTB in mESC. The distribution of all 
18 to 40 nt RPFs aligned to the housekeeping gene ACTB in ribosome profiling of mESC, top left, 
which depicts the enrichment of 28-30 nt reads indicative of RPFs protected by ribosomes during 
cycloheximide treatment. Also shown are example read length distribution profiles at various 
weighted biases (1.0 to 2.0) after sampling 10,000 RPFs from ACTB. As the weighted bias 
increases from 1.0 to 2.0, the distribution of read lengths increases in variance relative to the 
experimental read length distribution profile (“All Reads”) and adopts a progressively uniform 
distribution.  
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Figure A.2. Distribution of SPECtre scores over ACTB after weighted re-sampling. Re-sampling 
analysis of 10,000 RPFs with various weighted biases (from 1.0 to 2.0).  Dark line inside boxes 
denotes the median of the SPECtre scores at each weighted bias level, and whiskers depict the 
minimum and maximum scores. Solid horizontal line denotes the mean SPECtre score over all 
sampling simulations. The dashed, horizontal lines depict the extreme outlier boundaries as 
defined by Tukey, which is 1.5 times the IQR. 
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APPENDIX B 
SUPPLEMENTAL MATERIAL FOR CHAPTER 3 
 
A.1 Materials and Methods 
 
Alignment to the human genome and transcriptome (GRCh38 Ensembl version 78) 
Ribosome profiling and mRNA-Seq reads were trimmed of adapters, and then by quality using 
fasqt-mcf from the ea-utils package (https://github.com/ExpressionAnalysis/ea-utils). Ribosome 
profiling and mRNA-Seq reads in FASTQ format were trimmed based on quality if four 
consecutive nucleotides were observed with Phred scores of 10 or below. The minimum read 
length required after trimming was 25 nucleotides. Trimmed sequences were then aligned to a 
ribosomal RNA sequence index using Bowtie v1.1.2 to deplete them of contaminant 
sequences.[62] Alignment to the rRNA sequence contaminant index was performed using the 
following parameters: seed alignment length of 22 nucleotides, no mismatches in the seed 
alignment were allowed, with the unmapped reads written to a separate FASTQ file. 
bowtie -l 22 -n 0 -S --un /path/to/depleted_reads.fq \ 
  /path/to/rRNA_index \ 
  /path/to/trimmed_reads.fq 
Ribosome profiling and mRNA-Seq reads depleted of rRNA contaminant sequences were aligned 
to the human genome and transcriptome using TopHat v.2.0.0.[64,183] The trimmed and rRNA-
depleted reads were aligned to the human genome and transcriptome with the parameters 
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specifying standard Illumina reads, with un-gapped Bowtie 1 alignment (using a seed alignment 
length of 22 nucleotides, with no mismatches in the seed alignment allowed), to annotated 
junctions only, using Solexa quality scores: 
 tophat2 -p 4 –bowtie1 \ 
–-no-novel-juncs \ 
--library-type fr-unstranded \ 
--solexa-quals \ 
-G /path/to/ensembl.gtf \ 
/path/to/bowtie_index \ 
/path/to/depleted_reads.fq 
 
Sequence alignment quality filtering and merging 
Ribosome profiling and mRNA-Seq reads aligned to the human genome and transcriptome by 
TopHat2 were output to BAM format, and then sorted by chromosomal coordinate. Reads were 
then filtered by mapping quality using SAMTools; read alignments were required to have 
minimum mapping quality of 10, or higher, to be retained for subsequent analyses. Unique read 
group identifiers were assigned to each technical and biological replicate, and then the alignments 
were merged by technical replicates and subsequently as biological replicates using Picard 
(http://broadinstitute.github.io/picard/).[184] 
 
Metagene profile generation and alignment offset calculation 
For counting reads over transcript isoforms, metagene profiles were generated from the Ensembl 
(version 78) transcript annotation database using Plastid.[93] A- and P-site offsets for 
harringtonine and cycloheximide ribosome profiling reads, respectively, were determined by 
pooling all reads that overlapped canonical AUG translation initiation start sites from annotated 
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protein-coding genes. The most common (mode) distance from the 5’ ends of reads of a given 
length to the position of the AUG in those reads was accepted as the A- or P-site offset distance. 
 
Calculation of transcript abundance 
Read counts over each transcript isoform, or region (5’UTR, CDS, and 3’UTR), were normalized 
by length, summed, and reported as transcripts per million as described previously.[68] At the time 
of analysis, Cufflinks was required for initial transcript quality control, and was run with the 
following parameters:[58] 
 cufflinks -p 8 -o /path/to/output \ 
  -G /path/to/ensemble.gtf \ 
  /path/to/tophat/alignments 
 
SPECtre analysis of transcripts in non-differentiated and RA-differentiated libraries 
SPECtre profiling measures the strength of the tri-nucleotide periodicity inherent to the alignment 
of ribosome protected fragments to protein-coding genes in a reference transcriptome.[96] 
SPECtre analysis was applied in two stages: 1) to score the translational potential of annotated 
transcripts to build a background protein-coding reference model, and 2) to score the translational 
potential of predicted upstream-initiation ORFs. In this way, the translational potential of predicted 
upstream and overlapping ORFs are score against a background model of translation derived from 
annotated protein-coding transcripts. Annotated protein-coding transcripts were profiled by 
SPECtre using the following parameters: 
python /path/to/SPECtre.py \ 
 --input /path/to/tophat/alignments \ 
 --output /path/to/output \ 
 --log /path/to/logfile \ 
 --gtf /path/to/ensemble.gtf \ 
 --fpkm /path/to/cufflinks/isoforms.fpkm_tracking \ 
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 --len 30 \ 
 --fdr 0.05 \ 
 --min 3.0 \ 
 --nt 8 \ 
 --type mean \ 
 --target <chromosome_id> 
Where the minimum FPKM required for a transcript to be considered as translated for generation 
of the background model was specified as 3.0, and the length of the sliding SPECtre windows was 
set to encompass 30 nucleotides. The SPECtre score for a transcript was defined as the mean of 
the scores over these sliding windows, and a 5% false discovery rate was established to set the 
minimum SPECtre translational score threshold. In addition, SPECtre profiling was split by 
chromosome to speed computation, and the results were merged afterwards using a custom Python 
script. Finally, prior to analysis of predicted upstream-initiated ORFs by SPECtre profiling, the 
minimum SPECtre translational threshold was re-calculated using TPM instead of FPKM using a 
minimum cutoff of 10 transcripts per million. 
 
Computational prediction of upstream-initiated open reading frames 
Open reading frames were computationally predicted from annotated 5’UTR sequences (Ensembl, 
version 78) using AUG, and near-cognate non-AUG translation initiation site sequences. Open 
reading frame sequences were generated based on these predicted initiation site sequences and 
read through to the first in-frame termination codon encountered in the annotated CDS. These 
predicted ORFs were then used to generate coordinates over which they would be profiled and 
scored by SPECtre. Identical parameters to the annotated transcript SPECtre analysis were 
employed for consistency across analyses: 
 python /path/to/SPECtre-uORFs.py \ 
  --input /path/to/alignments \ 
  --output /path/to/output \ 
  --results /path/to/spectre/transcript_results \ 
  --log /path/to/logfile \ 
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  --fpkm /path/to/cufflinks/isoforms.fpkm_tracking \ 
  --len 30 \ 
  --fdr 0.05 \ 
  --min 3.0 \ 
  --nt 8 \ 
  --type mean \ 
  --target <chromosome_id> 
Three alternative inputs are required for the SPECtre analysis of predicted ORFs: 1) the annotated 
transcript GTF database was not required and removed, 2) the results of the annotated transcript 
analysis, and 3) a genomic sequence file in FASTA format. The results of the annotated transcript 
analysis were used to identify the set of transcripts from which to predict upstream-initiated ORFs, 
and the FASTA sequence file was used to generated the ORF sequences for output. 
 
Supplemental annotation of non-AUG translation initiation sites 
Upstream sequences of predicted non-AUG translation initiation sites were examined for possible 
in-frame AUG initiation start sites; 5’UTR sequences of predicted non-AUG sites were extracted, 
and then searched for the presence of in-frame AUG sites. These non-AUG sites were then re-
annotated according to the proximity of upstream AUG initiation sites: those with an in-frame 
AUG site within 30 nucleotides of the predicted TIS, and those with an in-frame AUG site in-
frame, but beyond 30 nucleotides upstream of the predicted site. 
  
 125 
 
 
Figure B.1 Molecular function gene set enrichment based on mRNA rank-change analysis. A) Up-
regulated gene sets in RA differentiated include those related to receptor binding, and signaling. 
B) Down-regulated gene sets include those related to microtubule binding and ATPase activity. 
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Figure B.2 Cellular component gene set enrichment based on mRNA rank-change analysis. A) 
Enriched terms in up-regulated gene sets include those related to extracellular space. B) Down-
regulated gene sets include terms related to chromosome structure. 
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Figure B.3 Enrichment of up-regulated gene sets based on DE analysis of RPF counts. A) Enriched 
biological processes include those related to development. B) Signal transduction and receptor 
activity gene sets up-regulated in RA differentiated cells. C) Extracellular components are enriched 
in RA differentiated cells compared to non-differentiated cells. 
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Figure B.4 Enrichment of down-regulated gene sets based on DE analysis of RPF counts. A) 
Biological processes are enriched in terms related to chromosome structure and assembly. B) 
Molecular function terms are enriched for chromatin and structural binding. C) Cellular component 
terms are enriched for chromosome structure and DNA packaging. 
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Figure B.5 Molecular function gene set enrichment based on translational efficiency. A) 
Molecular function terms are enriched for structural components of the ribosome and tRNA 
binding. B) Down-regulated molecular function gene sets are enriched for small molecule and 
structural binding terms. 
  
 130 
 
 
Figure B.6 Cellular component gene set enrichment based on translational efficiency. A) Up-
regulated gene sets are enriched for terms relate to extracellular space. B) Down-regulated gene 
sets are enriched for terms related to chromosome structure. 
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gene_id transcript_id gene_name uorf_id dist mean_residual 
ENSG00000203814 ENST00000545683 HIST2H2BF ENST00000545683.1 -138 214.009660627775 
ENSG00000164919 ENST00000520468 COX6C ENST00000520468.56 -75 7.48415663679263 
ENSG00000131174 ENST00000481445 COX7B ENST00000481445.12 -128 6.05530073370224 
ENSG00000155090 ENST00000285407 KLF10 ENST00000285407.3 -300 4.6977592616836 
ENSG00000133639 ENST00000256015 BTG1 ENST00000256015.27 -238 4.37266835988406 
ENSG00000204954 ENST00000549478 C12orf73 ENST00000549478.43 -166 4.1335802850581 
ENSG00000135535 ENST00000413644 CD164 ENST00000413644.5 -250 4.0339389968682 
ENSG00000124596 ENST00000373154 OARD1 ENST00000373154.18 -263 3.94226656417065 
ENSG00000109099 ENST00000312280 PMP22 ENST00000312280.20 -110 3.75254432924282 
ENSG00000166482 ENST00000395592 MFAP4 ENST00000395592.5 -290 3.50409809285365 
ENSG00000111897 ENST00000339697 SERINC1 ENST00000339697.8 -92 3.05084168188823 
ENSG00000220205 ENST00000316509 VAMP2 ENST00000316509.2 -234 2.7827129178595 
ENSG00000074695 ENST00000251047 LMAN1 ENST00000251047.80 -247 2.78027152995272 
ENSG00000132406 ENST00000254742 TMEM128 ENST00000254742.75 -115 2.7544412241449 
ENSG00000115128 ENST00000233468 SF3B6 ENST00000233468.18 -47 2.72897736886105 
ENSG00000169020 ENST00000304312 ATP5I ENST00000304312.11 -101 2.67511502668913 
ENSG00000165389 ENST00000298130 SPTSSA ENST00000298130.13 -203 2.46326924453185 
ENSG00000052723 ENST00000369528 SIKE1 ENST00000369528.6 -196 2.36628068847243 
ENSG00000006468 ENST00000420159 ETV1 ENST00000420159.40 -155 2.33053818614439 
ENSG00000127540 ENST00000591899 UQCR11 ENST00000591899.2 -158 2.30110461157947 
ENSG00000213420 ENST00000292377 GPC2 ENST00000292377.6 -170 2.20948360358882 
ENSG00000168002 ENST00000301788 POLR2G ENST00000301788.10 -138 2.06215949129986 
ENSG00000115128 ENST00000233468 SF3B6 ENST00000233468.20 -165 2.02599419353475 
ENSG00000189043 ENST00000339600 NDUFA4 ENST00000339600.22 -46 1.92194154519564 
ENSG00000129055 ENST00000510994 ANAPC13 ENST00000510994.101 -104 1.91685522041752 
ENSG00000085063 ENST00000351554 CD59 ENST00000351554.2 -186 1.90037524822165 
ENSG00000179085 ENST00000368400 DPM3 ENST00000368400.3 -196 1.86546022606256 
ENSG00000079950 ENST00000367941 STX7 ENST00000367941.14 -180 1.86084708595664 
ENSG00000271601 ENST00000604000 LIX1L ENST00000604000.7 -295 1.78284169077653 
ENSG00000205208 ENST00000379205 C4orf46 ENST00000379205.26 -215 1.76679586370253 
ENSG00000111237 ENST00000447578 VPS29 ENST00000447578.54 -227 1.53321434735956 
ENSG00000128609 ENST00000355749 NDUFA5 ENST00000355749.57 -199 1.52085271342457 
ENSG00000079150 ENST00000424785 FKBP7 ENST00000424785.4 -105 1.50839437465663 
ENSG00000060762 ENST00000621630 MPC1 ENST00000621630.11 -265 1.3516320650817 
ENSG00000154582 ENST00000520210 TCEB1 ENST00000520210.15 -113 1.34924892563321 
ENSG00000006468 ENST00000403685 ETV1 ENST00000403685.26 -207 1.33192548256211 
ENSG00000124172 ENST00000243997 ATP5E ENST00000243997.8 -107 1.24867441318077 
ENSG00000091136 ENST00000222399 LAMB1 ENST00000222399.4 -269 1.1749046682958 
ENSG00000176454 ENST00000617710 LPCAT4 ENST00000617710.55 -232 1.10552942043999 
ENSG00000134825 ENST00000537328 TMEM258 ENST00000537328.3 -176 1.0859091551629 
ENSG00000163191 ENST00000271638 S100A11 ENST00000271638.2 -183 1.02524457965488 
ENSG00000155957 ENST00000556010 TMBIM4 ENST00000556010.3 -179 1.02038839594092 
ENSG00000196628 ENST00000354452 TCF4 ENST00000354452.67 -152 1.003257734837 
ENSG00000127452 ENST00000247977 FBXL12 ENST00000247977.19 -171 0.985331204079753 
ENSG00000117122 ENST00000375535 MFAP2 ENST00000375535.19 -65 0.982748606719541 
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ENSG00000184047 ENST00000443649 DIABLO ENST00000443649.70 -115 0.981005829474638 
ENSG00000125827 ENST00000246024 TMX4 ENST00000246024.17 -274 0.912146644073427 
ENSG00000132432 ENST00000352861 SEC61G ENST00000352861.1 -185 0.911388696044815 
ENSG00000085832 ENST00000371733 EPS15 ENST00000371733.1 -277 0.906480145192362 
ENSG00000150093 ENST00000396033 ITGB1 ENST00000396033.2 -85 0.875993375496484 
ENSG00000198668 ENST00000544280 CALM1 ENST00000544280.24 -35 0.844908638059924 
ENSG00000105438 ENST00000330720 KDELR1 ENST00000330720.3 -190 0.830959779619959 
ENSG00000151552 ENST00000281243 QDPR ENST00000281243.3 -169 0.8234164379142 
ENSG00000100906 ENST00000216797 NFKBIA ENST00000216797.1 -254 0.804658104953933 
ENSG00000244754 ENST00000357505 N4BP2L2 ENST00000357505.24 -91 0.797754000974177 
ENSG00000164054 ENST00000612611 SHISA5 ENST00000612611.40 -186 0.790012045975735 
ENSG00000166228 ENST00000299299 PCBD1 ENST00000299299.18 -174 0.757990861931869 
ENSG00000196628 ENST00000537578 TCF4 ENST00000537578.70 -92 0.738709289790308 
ENSG00000130731 ENST00000614890 C16orf13 ENST00000614890.3 -229 0.73678431471042 
ENSG00000025796 ENST00000369002 SEC63 ENST00000369002.16 -233 0.735344058921464 
ENSG00000114503 ENST00000321256 NCBP2 ENST00000321256.4 -83 0.733913690913015 
ENSG00000168374 ENST00000303436 ARF4 ENST00000303436.17 -112 0.727015552079459 
ENSG00000133983 ENST00000389912 COX16 ENST00000389912.14 -76 0.676840640464102 
ENSG00000136240 ENST00000258739 KDELR2 ENST00000258739.8 -179 0.65800456276373 
ENSG00000075142 ENST00000394641 SRI ENST00000394641.1 -82 0.609081354350244 
ENSG00000113575 ENST00000481195 PPP2CA ENST00000481195.21 -107 0.597347838969469 
ENSG00000127922 ENST00000248566 SHFM1 ENST00000248566.1 -95 0.564001102458755 
ENSG00000155380 ENST00000538576 SLC16A1 ENST00000538576.98 -245 0.546894116837497 
ENSG00000110090 ENST00000376618 CPT1A ENST00000376618.8 -69 0.536384072657107 
ENSG00000105223 ENST00000409281 PLD3 ENST00000409281.25 -60 0.507684483232725 
ENSG00000001630 ENST00000450723 CYP51A1 ENST00000450723.26 -194 0.486296029848002 
ENSG00000134153 ENST00000256545 EMC7 ENST00000256545.8 -263 0.454876567454237 
ENSG00000138069 ENST00000398529 RAB1A ENST00000398529.22 -49 0.430983967101631 
ENSG00000132388 ENST00000396981 UBE2G1 ENST00000396981.2 -88 0.409590512755403 
ENSG00000140307 ENST00000396060 GTF2A2 ENST00000396060.16 -57 0.357284091058508 
ENSG00000185088 ENST00000330964 RPS27L ENST00000330964.35 -257 0.324956326333918 
ENSG00000131238 ENST00000433473 PPT1 ENST00000433473.59 -164 0.315578296532823 
ENSG00000119655 ENST00000555619 NPC2 ENST00000555619.5 -204 0.300166259008394 
ENSG00000154723 ENST00000284971 ATP5J ENST00000284971.4 -185 0.294405818784438 
ENSG00000063241 ENST00000438389 ISOC2 ENST00000438389.79 -245 0.289505438369753 
ENSG00000147255 ENST00000370910 IGSF1 ENST00000370910.13 -194 0.265933110942999 
ENSG00000135404 ENST00000420846 CD63 ENST00000420846.2 -85 0.262074002549052 
ENSG00000172270 ENST00000545507 BSG ENST00000545507.44 -129 0.246795080303511 
ENSG00000112514 ENST00000374496 CUTA ENST00000374496.30 -211 0.229477885271077 
ENSG00000109065 ENST00000357814 NAT9 ENST00000357814.1 -275 0.21946453747034 
ENSG00000035862 ENST00000262768 TIMP2 ENST00000262768.12 -155 0.183231194207834 
ENSG00000146425 ENST00000367089 DYNLT1 ENST00000367089.1 -96 0.168063833021454 
ENSG00000104763 ENST00000262097 ASAH1 ENST00000262097.10 -298 0.167143529270821 
ENSG00000170540 ENST00000304414 ARL6IP1 ENST00000304414.12 -101 0.162134795098452 
ENSG00000182117 ENST00000328848 NOP10 ENST00000328848.2 -62 0.157873730955841 
ENSG00000183010 ENST00000329875 PYCR1 ENST00000329875.1 -91 0.147765411511009 
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ENSG00000116791 ENST00000370871 CRYZ ENST00000370871.9 -179 0.146769664775778 
ENSG00000123933 ENST00000337190 MXD4 ENST00000337190.17 -223 0.139839506501833 
ENSG00000100219 ENST00000611155 XBP1 ENST00000611155.1 -290 0.118515717745031 
ENSG00000100528 ENST00000216416 CNIH1 ENST00000216416.3 -273 0.10299321646171 
ENSG00000137876 ENST00000260443 RSL24D1 ENST00000260443.12 -57 0.101922613166617 
ENSG00000127184 ENST00000247655 COX7C ENST00000247655.4 -47 0.0990643451928337 
ENSG00000143158 ENST00000271373 MPC2 ENST00000271373.2 -227 0.0953577701619 
ENSG00000118181 ENST00000527673 RPS25 ENST00000527673.41 -138 0.0930416477215578 
ENSG00000148248 ENST00000545297 SURF4 ENST00000545297.1 -257 0.0817327574752148 
ENSG00000137868 ENST00000323940 STRA6 ENST00000323940.25 -215 0.0807719741579371 
ENSG00000141378 ENST00000393038 PTRH2 ENST00000393038.25 -201 0.0730939487486646 
ENSG00000008283 ENST00000392975 CYB561 ENST00000392975.10 -239 0.0707678951588921 
ENSG00000175768 ENST00000544379 TOMM5 ENST00000544379.1 -48 0.0603761698132674 
ENSG00000171497 ENST00000307720 PPID ENST00000307720.3 -245 0.054817771060998 
ENSG00000004779 ENST00000007516 NDUFAB1 ENST00000007516.2 -223 0.0533917499232271 
ENSG00000175334 ENST00000312175 BANF1 ENST00000312175.47 -83 0.0523633662762182 
ENSG00000188486 ENST00000530167 H2AFX ENST00000530167.4 -184 0.050800413281085 
ENSG00000138071 ENST00000377982 ACTR2 ENST00000377982.9 -56 0.0311450513673084 
ENSG00000132254 ENST00000423813 ARFIP2 ENST00000423813.22 -279 0.0201223202987942 
ENSG00000080644 ENST00000348639 CHRNA3 ENST00000348639.27 -228 -0.0161047158214547 
ENSG00000065518 ENST00000184266 NDUFB4 ENST00000184266.2 -237 -0.0236689183432249 
ENSG00000197696 ENST00000360476 NMB ENST00000360476.21 -260 -0.0280671285411302 
ENSG00000138175 ENST00000260746 ARL3 ENST00000260746.3 -186 -0.0313722248469262 
ENSG00000117519 ENST00000370206 CNN3 ENST00000370206.27 -109 -0.0326596808454877 
ENSG00000132635 ENST00000360652 PCED1A ENST00000360652.46 -222 -0.0611921218654977 
ENSG00000132635 ENST00000356872 PCED1A ENST00000356872.25 -213 -0.0628914166351539 
ENSG00000141425 ENST00000589050 RPRD1A ENST00000589050.18 -194 -0.0707040015394569 
ENSG00000164733 ENST00000353047 CTSB ENST00000353047.4 -236 -0.111293748701263 
ENSG00000140264 ENST00000409960 SERF2 ENST00000409960.5 -47 -0.113307644512048 
ENSG00000167476 ENST00000300961 JSRP1 ENST00000300961.2 -251 -0.128486638479777 
ENSG00000129084 ENST00000396394 PSMA1 ENST00000396394.35 -202 -0.147381257217403 
ENSG00000117519 ENST00000545882 CNN3 ENST00000545882.16 -64 -0.163556663489164 
ENSG00000120889 ENST00000347739 TNFRSF10B ENST00000347739.11 -276 -0.190360894329478 
ENSG00000179348 ENST00000487848 GATA2 ENST00000487848.36 -238 -0.20776396821143 
ENSG00000122566 ENST00000356674 HNRNPA2B1 ENST00000356674.1 -49 -0.209723429231841 
ENSG00000182004 ENST00000414487 SNRPE ENST00000414487.1 -112 -0.210668985977755 
ENSG00000185825 ENST00000345046 BCAP31 ENST00000345046.25 -230 -0.214869710580321 
ENSG00000055950 ENST00000342071 MRPL43 ENST00000342071.2 -154 -0.244590604054466 
ENSG00000183648 ENST00000329559 NDUFB1 ENST00000329559.1 -236 -0.249336665428592 
ENSG00000099800 ENST00000215570 TIMM13 ENST00000215570.29 -66 -0.256667910963101 
ENSG00000105341 ENST00000417807 ATP5SL ENST00000417807.2 -224 -0.273074886882529 
ENSG00000108774 ENST00000346213 RAB5C ENST00000346213.16 -200 -0.291555465067221 
ENSG00000136238 ENST00000356142 RAC1 ENST00000356142.11 -48 -0.309149894800538 
ENSG00000162704 ENST00000294742 ARPC5 ENST00000294742.2 -251 -0.310841352790972 
ENSG00000173726 ENST00000366607 TOMM20 ENST00000366607.19 -177 -0.31629214760063 
ENSG00000044574 ENST00000324460 HSPA5 ENST00000324460.22 -226 -0.324808659740707 
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ENSG00000198728 ENST00000425280 LDB1 ENST00000425280.21 -205 -0.328098825393004 
ENSG00000127054 ENST00000545578 CPSF3L ENST00000545578.32 -34 -0.346771974303562 
ENSG00000257727 ENST00000273308 CNPY2 ENST00000273308.50 -115 -0.361479253612223 
ENSG00000100320 ENST00000449924 RBFOX2 ENST00000449924.28 -178 -0.377114632250786 
ENSG00000184983 ENST00000498737 NDUFA6 ENST00000498737.4 -263 -0.387230673983785 
ENSG00000165609 ENST00000537776 NUDT5 ENST00000537776.46 -243 -0.389163058867658 
ENSG00000166595 ENST00000422424 FAM96B ENST00000422424.2 -164 -0.416418250402919 
ENSG00000141759 ENST00000355491 TXNL4A ENST00000355491.4 -117 -0.418189757568447 
ENSG00000105968 ENST00000308153 H2AFV ENST00000308153.1 -240 -0.424636284455856 
ENSG00000116521 ENST00000355379 SCAMP3 ENST00000355379.25 -216 -0.437214601833621 
ENSG00000127054 ENST00000540437 CPSF3L ENST00000540437.25 -159 -0.439294660545869 
ENSG00000138801 ENST00000265174 PAPSS1 ENST00000265174.1 -206 -0.439849329893503 
ENSG00000163634 ENST00000469584 THOC7 ENST00000469584.7 -116 -0.444284451057211 
ENSG00000112514 ENST00000374496 CUTA ENST00000374496.33 -293 -0.453853258843619 
ENSG00000115944 ENST00000234301 COX7A2L ENST00000234301.4 -213 -0.462732554413591 
ENSG00000069275 ENST00000367142 NUCKS1 ENST00000367142.29 -72 -0.463025123513495 
ENSG00000124795 ENST00000397239 DEK ENST00000397239.17 -296 -0.47428935467215 
ENSG00000162704 ENST00000294742 ARPC5 ENST00000294742.11 -270 -0.481661270747767 
ENSG00000135052 ENST00000388711 GOLM1 ENST00000388711.8 -196 -0.483779734693854 
ENSG00000143870 ENST00000381611 PDIA6 ENST00000381611.43 -285 -0.490962260426038 
ENSG00000099817 ENST00000615234 POLR2E ENST00000615234.2 -85 -0.495810750555621 
ENSG00000126756 ENST00000335890 UXT ENST00000335890.17 -225 -0.508973607855719 
ENSG00000074201 ENST00000525428 CLNS1A ENST00000525428.7 -185 -0.516719181922892 
ENSG00000198937 ENST00000373408 CCDC167 ENST00000373408.4 -170 -0.520165640348613 
ENSG00000198728 ENST00000361198 LDB1 ENST00000361198.54 -293 -0.523296105130001 
ENSG00000075945 ENST00000367767 KIFAP3 ENST00000367767.1 -216 -0.525185520231444 
ENSG00000241837 ENST00000290299 ATP5O ENST00000290299.16 -114 -0.530476937321087 
ENSG00000116521 ENST00000302631 SCAMP3 ENST00000302631.5 -162 -0.544239900223973 
ENSG00000095059 ENST00000210060 DHPS ENST00000210060.9 -262 -0.549621709551695 
ENSG00000237190 ENST00000458198 CDKN2AIPNL ENST00000458198.2 -259 -0.585034855183767 
ENSG00000109332 ENST00000343106 UBE2D3 ENST00000343106.56 -32 -0.590322600719257 
ENSG00000106153 ENST00000395422 CHCHD2 ENST00000395422.18 -67 -0.592354933593252 
ENSG00000141551 ENST00000392334 CSNK1D ENST00000392334.2 -175 -0.599562601212801 
ENSG00000147123 ENST00000276062 NDUFB11 ENST00000276062.39 -230 -0.617319760348337 
ENSG00000136709 ENST00000322313 WDR33 ENST00000322313.6 -254 -0.621102190485708 
ENSG00000151694 ENST00000310823 ADAM17 ENST00000310823.14 -107 -0.623032840210605 
ENSG00000255526 ENST00000534348 NEDD8-MDP1 ENST00000534348.6 -41 -0.637645524984602 
ENSG00000137726 ENST00000614497 FXYD6 ENST00000614497.37 -241 -0.6428314299647 
ENSG00000177889 ENST00000318066 UBE2N ENST00000318066.27 -217 -0.643060374623743 
ENSG00000082898 ENST00000401558 XPO1 ENST00000401558.73 -173 -0.662760870411819 
ENSG00000003096 ENST00000540167 KLHL13 ENST00000540167.41 -201 -0.675720176705533 
ENSG00000122565 ENST00000396386 CBX3 ENST00000396386.12 -60 -0.683349890817454 
ENSG00000120742 ENST00000239944 SERP1 ENST00000239944.38 -202 -0.707968706666024 
ENSG00000174886 ENST00000418389 NDUFA11 ENST00000418389.1 -103 -0.719015849826662 
ENSG00000171858 ENST00000343986 RPS21 ENST00000343986.3 -104 -0.72813144001002 
ENSG00000115524 ENST00000414963 SF3B1 ENST00000414963.6 -166 -0.731510873150678 
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ENSG00000164885 ENST00000618146 CDK5 ENST00000618146.1 -231 -0.732739593101115 
ENSG00000177885 ENST00000316804 GRB2 ENST00000316804.24 -98 -0.75006859660494 
ENSG00000143543 ENST00000271843 JTB ENST00000271843.35 -220 -0.750328469205788 
ENSG00000119977 ENST00000614499 TCTN3 ENST00000614499.11 -278 -0.751308528604164 
ENSG00000089693 ENST00000203630 MLF2 ENST00000203630.49 -113 -0.760283418051521 
ENSG00000160075 ENST00000291386 SSU72 ENST00000291386.22 -267 -0.778292785332658 
ENSG00000119977 ENST00000614499 TCTN3 ENST00000614499.19 -235 -0.782267935996206 
ENSG00000142192 ENST00000359726 APP ENST00000359726.15 -85 -0.790181138564981 
ENSG00000153048 ENST00000614449 CARHSP1 ENST00000614449.11 -248 -0.802418347039104 
ENSG00000135404 ENST00000546939 CD63 ENST00000546939.19 -187 -0.803368215438916 
ENSG00000130255 ENST00000347512 RPL36 ENST00000347512.9 -101 -0.811787342946931 
ENSG00000177733 ENST00000314940 HNRNPA0 ENST00000314940.12 -99 -0.834038425010562 
ENSG00000003096 ENST00000545703 KLHL13 ENST00000545703.38 -157 -0.856318603633122 
ENSG00000085662 ENST00000285930 AKR1B1 ENST00000285930.4 -85 -0.858164998065364 
ENSG00000157593 ENST00000615337 SLC35B2 ENST00000615337.30 -62 -0.872562096514651 
ENSG00000170315 ENST00000302182 UBB ENST00000302182.46 -47 -0.881379772837001 
ENSG00000255245 ENST00000532984 FXYD6-FXYD2 ENST00000532984.2 -189 -0.906592968898827 
ENSG00000143320 ENST00000368222 CRABP2 ENST00000368222.9 -194 -0.920319738044272 
ENSG00000175203 ENST00000434715 DCTN2 ENST00000434715.1 -264 -0.924330527292718 
ENSG00000154518 ENST00000284727 ATP5G3 ENST00000284727.403 -107 -0.929179765605121 
ENSG00000139116 ENST00000544797 KIF21A ENST00000544797.4 -282 -0.948718767014162 
ENSG00000143570 ENST00000537590 SLC39A1 ENST00000537590.18 -245 -0.961637016549463 
ENSG00000107223 ENST00000371649 EDF1 ENST00000371649.1 -221 -0.995249121854717 
ENSG00000123144 ENST00000242784 C19orf43 ENST00000242784.9 -168 -1.01048357917033 
ENSG00000242485 ENST00000344843 MRPL20 ENST00000344843.8 -245 -1.03841132995427 
ENSG00000143612 ENST00000368521 C1orf43 ENST00000368521.16 -176 -1.05801058344335 
ENSG00000088247 ENST00000398148 KHSRP ENST00000398148.2 -289 -1.0731766875609 
ENSG00000198931 ENST00000378364 APRT ENST00000378364.3 -194 -1.08043123202743 
ENSG00000167397 ENST00000354895 VKORC1 ENST00000354895.17 -279 -1.08501853897882 
ENSG00000136942 ENST00000348462 RPL35 ENST00000348462.1 -55 -1.11092721218343 
ENSG00000258947 ENST00000554444 TUBB3 ENST00000554444.48 -47 -1.13801419643665 
ENSG00000115694 ENST00000535007 STK25 ENST00000535007.48 -177 -1.13963411524601 
ENSG00000034510 ENST00000233143 TMSB10 ENST00000233143.7 -44 -1.14096665432478 
ENSG00000115053 ENST00000322723 NCL ENST00000322723.20 -73 -1.16138760059223 
ENSG00000166794 ENST00000300026 PPIB ENST00000300026.1 -103 -1.16953472834137 
ENSG00000110492 ENST00000617138 MDK ENST00000617138.4 -189 -1.17000997680216 
ENSG00000143321 ENST00000537739 HDGF ENST00000537739.3 -115 -1.18796584105409 
ENSG00000177576 ENST00000318240 C18orf32 ENST00000318240.10 -215 -1.20279837697525 
ENSG00000117362 ENST00000414276 APH1A ENST00000414276.29 -266 -1.21853461513679 
ENSG00000108424 ENST00000540627 KPNB1 ENST00000540627.44 -89 -1.21856829614583 
ENSG00000178952 ENST00000313511 TUFM ENST00000313511.1 -254 -1.22149508261608 
ENSG00000168066 ENST00000334944 SF1 ENST00000334944.30 -97 -1.25158240344226 
ENSG00000163479 ENST00000295702 SSR2 ENST00000295702.1 -166 -1.25725161846665 
ENSG00000100902 ENST00000622405 PSMA6 ENST00000622405.28 -158 -1.2804061012882 
ENSG00000110700 ENST00000525634 RPS13 ENST00000525634.11 -211 -1.28300049594478 
ENSG00000108106 ENST00000264552 UBE2S ENST00000264552.8 -188 -1.2879586388961 
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ENSG00000104964 ENST00000327141 AES ENST00000327141.18 -188 -1.29481151581135 
ENSG00000161016 ENST00000394920 RPL8 ENST00000394920.11 -70 -1.29782642237 
ENSG00000142676 ENST00000374550 RPL11 ENST00000374550.2 -101 -1.31087487320222 
ENSG00000196531 ENST00000393891 NACA ENST00000393891.32 -174 -1.31186245873421 
ENSG00000109971 ENST00000534624 HSPA8 ENST00000534624.29 -236 -1.3264140797818 
ENSG00000144381 ENST00000345042 HSPD1 ENST00000345042.4 -187 -1.33061886541826 
ENSG00000117362 ENST00000369109 APH1A ENST00000369109.7 -284 -1.34175935016826 
ENSG00000196683 ENST00000621567 TOMM7 ENST00000621567.6 -151 -1.36980326886019 
ENSG00000111669 ENST00000535434 TPI1 ENST00000535434.54 -77 -1.38001713319878 
ENSG00000163682 ENST00000295955 RPL9 ENST00000295955.1 -61 -1.38088773408104 
ENSG00000143321 ENST00000537739 HDGF ENST00000537739.1 -92 -1.39061940279209 
ENSG00000186468 ENST00000296674 RPS23 ENST00000296674.10 -174 -1.44965277767312 
ENSG00000204628 ENST00000512805 GNB2L1 ENST00000512805.39 -113 -1.45038996618863 
ENSG00000167552 ENST00000295766 TUBA1A ENST00000295766.34 -231 -1.45062087065742 
ENSG00000009307 ENST00000358528 CSDE1 ENST00000358528.55 -203 -1.49839302412736 
ENSG00000103202 ENST00000620944 NME4 ENST00000620944.26 -95 -1.53451110959796 
ENSG00000159335 ENST00000309083 PTMS ENST00000309083.13 -267 -1.5606760064114 
ENSG00000233276 ENST00000620890 GPX1 ENST00000620890.7 -278 -1.56560616045304 
ENSG00000197111 ENST00000359462 PCBP2 ENST00000359462.9 -273 -1.56729601762157 
ENSG00000067225 ENST00000389093 PKM ENST00000389093.23 -182 -1.57705878064094 
ENSG00000169100 ENST00000381401 SLC25A6 ENST00000381401.59 -281 -1.67459365341014 
ENSG00000110321 ENST00000396525 EIF4G2 ENST00000396525.6 -262 -1.68307949354514 
ENSG00000110700 ENST00000525634 RPS13 ENST00000525634.4 -93 -1.7321324821891 
ENSG00000142937 ENST00000396651 RPS8 ENST00000396651.12 -157 -1.76170933476306 
ENSG00000134419 ENST00000322989 RPS15A ENST00000322989.5 -152 -1.78851234605872 
ENSG00000131051 ENST00000528062 RBM39 ENST00000528062.29 -132 -1.84378825807836 
ENSG00000166441 ENST00000314138 RPL27A ENST00000314138.38 -103 -1.9364870969166 
ENSG00000114942 ENST00000392221 EEF1B2 ENST00000392221.11 -117 -1.95726819118581 
ENSG00000161016 ENST00000262584 RPL8 ENST00000262584.17 -209 -1.99567572901688 
ENSG00000125691 ENST00000479035 RPL23 ENST00000479035.15 -89 -2.16195520179977 
ENSG00000186591 ENST00000473814 UBE2H ENST00000473814.1 -141 -2.21344944622502 
ENSG00000071553 ENST00000619046 ATP6AP1 ENST00000619046.172 -130 -3.08107352094565 
ENSG00000143761 ENST00000540651 ARF1 ENST00000540651.19 -130 -3.09310292609271 
ENSG00000143621 ENST00000615950 ILF2 ENST00000615950.16 -143 -4.30466650102223 
ENSG00000143256 ENST00000368010 PFDN2 ENST00000368010.6 -137 -4.98448083590993 
ENSG00000096092 ENST00000211314 TMEM14A ENST00000211314.14 -147 -5.09234161017485 
ENSG00000183291 ENST00000611507 SEP15 ENST00000611507.44 -143 -5.18003689109536 
ENSG00000074800 ENST00000234590 ENO1 ENST00000234590.7 -134 -5.49295117979661 
ENSG00000170759 ENST00000302418 KIF5B ENST00000302418.41 -146 -6.19660816181915 
ENSG00000100612 ENST00000557185 DHRS7 ENST00000557185.8 -149 -6.22478403761334 
ENSG00000003096 ENST00000545703 KLHL13 ENST00000545703.41 -122 -6.66550073978611 
ENSG00000175130 ENST00000329421 MARCKSL1 ENST00000329421.12 -134 -7.56901600568944 
ENSG00000156261 ENST00000540844 CCT8 ENST00000540844.43 -128 -7.95648179447574 
ENSG00000179010 ENST00000382581 MRFAP1 ENST00000382581.7 -127 -8.26393702815768 
ENSG00000145817 ENST00000513112 YIPF5 ENST00000513112.38 -140 -8.48938875645551 
ENSG00000140612 ENST00000559729 SEC11A ENST00000559729.29 -137 -8.76337578986518 
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ENSG00000137409 ENST00000538808 MTCH1 ENST00000538808.1 -140 -10.1088360945316 
ENSG00000197457 ENST00000370053 STMN3 ENST00000370053.2 -128 -10.2126643760176 
ENSG00000136758 ENST00000375972 YME1L1 ENST00000375972.14 -146 -10.2370870700578 
ENSG00000062582 ENST00000317534 MRPS24 ENST00000317534.2 -134 -10.6356602026815 
ENSG00000105825 ENST00000222543 TFPI2 ENST00000222543.19 -121 -10.836637711152 
ENSG00000171603 ENST00000361311 CLSTN1 ENST00000361311.14 -136 -12.3761242667669 
ENSG00000173457 ENST00000309318 PPP1R14B ENST00000309318.12 -139 -13.331635373616 
ENSG00000138382 ENST00000260953 METTL5 ENST00000260953.23 -134 -13.3901605910573 
ENSG00000075142 ENST00000265729 SRI ENST00000265729.2 -149 -13.5492239730267 
ENSG00000077147 ENST00000371142 TM9SF3 ENST00000371142.12 -136 -13.5495964783895 
ENSG00000196305 ENST00000375643 IARS ENST00000375643.28 -134 -16.3148281988894 
ENSG00000197958 ENST00000361436 RPL12 ENST00000361436.3 -132 -19.3191399380345 
 
Table B.1 Positive and negative residuals from multiple regression analysis of oORFs in RA 
differentiated SH-SY5Y cells. Genes are subset to those that terminate within 300 nt of the 
annotated TIS start site. 
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APPENDIX C 
SUPPLEMENTAL MATERIAL FOR CHAPTER 4 
 
C.1 Methods 
 
Integration of known fusion breakpoints from COSMIC: 
# Input files: 
cosmic_file = sys.argv[1] 
fasta_file = sys.argv[2] 
 
# Load FASTA sequence of gene transcripts: 
def load_fasta_file(infile): 
    fasta = dict() 
    for line in open(infile): 
        if line.startswith(">"): 
            transcript_id = line.strip().split(" ")[1] 
            fasta[transcript_id] = str() 
        else: 
            fasta[transcript_id] += line.strip() 
    return fasta 
 
seq = load_fasta_file(fasta_file) 
 
for line in open(cosmic_file): 
    fusion = line.strip() 
    # Extract gene names and transcript ids of fusion partners: 
    genes = [gene[:-1] for gene in re.findall("[a-zA-Z0-9]+{", fusion)] 
    transcripts = [transcript[:-1] for transcript in re.findall("[a-zA-Z0-9_.]+}", fusion)] 
    # Extract the breakpoint coordinates from HGVS annotation: 
    coordinates = re.findall("r.[0-9]+_[0-9]+", fusion) 
    fusion_sequences = list() 
    for x in xrange(len(transcripts)): 
        if transcripts[x] in seq: 
            fasta = seq[transcripts[x]] 
            # Start must be de-cremented by because Python is 0-based and HGVS coordinates are 1-based: 
            start = int(re.findall("[0-9]+", coordinates[x])[0]) - 1 
            end = int(re.findall("[0-9]+", coordinates[x])[-1]) 
            if x == 0: 
                fusion_sequences = [fasta[start:end]] 
            else: 
                fusion_sequences.append(fasta[start:end]) 
    # By default the breakpoint occurs between the first and second gene: 
    break_index = 1 
    last_gene = transcripts[0] 
    for x in xrange(len(transcripts)): 
        if transcripts[x] == last_gene: 
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            pass 
        else: 
            break_index = x 
    left_sequences = "".join(seq for seq in fusion_sequences[:break_index]) 
    right_sequences = "".join(seq for seq in fusion_sequences[break_index:]) 
    # Trim left sequence to last 30 nucleotides: 
    left_seq = left_sequences[len(left_sequences)-150:] 
    # Trim right sequence to first 30 nucleotides: 
    right_seq = right_sequences[:150] 
    # Generate the name of the fusion: 
    fusion_genes = ":".join(gene for gene in list(set(genes))) 
    fusion_transcripts = ":".join(transcript for transcript in list(set(transcripts))) 
    fusion_coordinates = ":".join(pos for pos in coordinates) 
    fusion_name = “>{COSMIC}|” + “|”.join(str(field) for field in [fusion_genes, fusion_transcripts, \ 
 fusion_coordinates, len(left_seq), len(right_seq)]) 
    #if len(left_seq + right_seq) == 60: 
    print fusion_name 
    print left_seq.upper() + right_seq.upper() 
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SRA ID Condition Method Paired Length Number of Reads Total Reads 
SRX848657 untreated mRNA Yes 102 41,064,374  
  97,394,360  
SRX848658 untreated mRNA Yes 102 56,329,986  
SRX1100334 untreated mRNA Yes 100 24,207,325  
  66,933,654  SRX1100335 untreated mRNA Yes 100 26,548,537  
SRX1100336 untreated mRNA Yes 100 16,177,792  
SRX209073 untreated mRNA Yes 102 9,690,701  
  21,641,312  
SRX209074 untreated mRNA Yes 102 11,950,611  
SRX118285 vehicle-treated mRNA No 40 22,153,049  
  46,628,839  
SRX118291 vehicle-treated mRNA No 40 24,475,790  
SRX118287 rapamycin mRNA No 40 21,878,806  
  40,996,269  
SRX118293 rapamycin mRNA No 40 19,117,463  
SRX118289 PP242 mRNA No 40 19,655,874  
  45,411,611  
SRX118295 PP242 mRNA No 40 25,755,737  
SRX118286 vehicle-treated RPF No 40 20,762,604  
  45,160,552  
SRX118292 vehicle-treated RPF No 40 24,397,948  
SRX118288 rapamycin RPF No 40 19,742,795  
  45,197,863  
SRX118294 rapamycin RPF No 40 25,455,068  
SRX118290 PP242 RPF No 40 19,706,845  
  44,998,520  
SRX118296 PP242 RPF No 40 25,291,675  
 
Table C.1 Paired-end and single-end sequencing PC-3 mRNA and ribosome profiling libraries 
used in this study.  
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Table C.2 Filtered set of previously annotated and novel STAR-FUSION gene fusions. 
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